Taussig Cancer Institute 2011 Publications

Journal Publications Abdel-Wahab M, Rosenblatt E, Holmberg O, Meghzifene A. Safety in radiation oncology: the role of international initiatives by the international atomic energy agency. J Am Coll Radiol. 2011 Nov;8(11):789-794.

Abraham J, Nelon LD, Kubicek CB, Kilcoyne A, Hampton ST, Zarzabal LA, Giles FJ, Michalek JE, Rubin BP, Keller C. Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model. Sarcoma. 2011;2011:130484.

Abraham J, Prajapati SI, Nishijo K, Schaffer BS, Taniguchi E, Kilcoyne A, McCleish AT, Nelon LD, Giles FG, Efstratiadis A, LeGallo RD, Nowak BM, Rubin BP, Malempati S, Keller C. Evasion mechanisms to igf1r inhibition in rhabdomyosarcoma. Mol Cancer Ther. 2011 Apr;10(4):697-707.

Adamson J, Zhuang T, Yin FF. Contour based respiratory motion analysis for free breathing CT. Comput Biol Med. 2011 Oct;41(10):908-915.

Adelstein DJ, Rodriguez CP. What is new in the management of salivary gland cancers? Curr Opin Oncol. 2011 May;23(3):249-253.

Advani AS, Gibson S, Douglas E, Diacovo J, Elson P, Kalaycio M, Copelan E, Sekeres M, Sobecks R, Sungren S, Lagoo A, Rizzieri D, Hsi E. Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL). Br J Haematol. 2011 May;153(4):504-507.

Advani AS. Blinatumomab: A novel agent to treat minimal residual disease in patients with acute lymphoblastic leukemia. Clin Adv Hematol Oncol. 2011 Oct;9(10):776-777.

Afable MG, Tiu RV, Maciejewski JP. Clonal evolution in aplastic anemia. Hematology Am Soc Hematol Educ Program. 2011;2011:90-95.

Afable MG, Shaik M, Sugimoto Y, Elson P, Clemente M, Makishima H, Sekeres MA, Lichtin A, Advani A, Kalaycio M, Tiu RV, O'Keefe CL, Maciejewski JP. Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia. Haematologica. 2011 Sep;96(9):1269-1275.

Afable MG, II, Wlodarski M, Makishima H, Shaik M, Sekeres MA, Tiu RV, Kalaycio M, O'Keefe CL, Maciejewski JP. SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes. Blood. 2011 Jun 23;117(25):6876-6884.

Aggarwal A, Mehta N, Shah SN. Small bowel angioedema associated with Angiotensin converting enzyme inhibitor use. J Gen Intern Med. 2011 Apr;26(4):446-447.

Ahluwalia MS, Wen PY. Antiangiogenic therapy for patients with glioblastoma: current challenges in imaging and future directions. Expert Rev Anticancer Ther. 2011 May;11(5):653-656.

Ahluwalia MS, Patel M, Peereboom DM. Role of tyrosine kinase inhibitors in the management of high-grade gliomas. Expert Rev Anticancer Ther. 2011 Nov;11(11):1739-1748.

Ahluwalia MS. American Society of Clinical Oncology 2011 CNS tumors update. Expert Rev Anticancer Ther. 2011 Oct;11(10):1495-1497.

Ahluwalia MS. 2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies. Expert Rev Anticancer Ther. 2011 Feb;11(2):161-163.

Ahluwalia MS, Patton C, Stevens G, Tekautz T, Angelov L, Vogelbaum MA, Weil RJ, Chao S, Elson P, Suh JH, Barnett GH, Peereboom DM. Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas. J Neurooncol. 2011 Apr;102(2):317-321.

Aktas A, Walsh D. Methodological challenges in supportive and palliative care cancer research. Semin Oncol. 2011 Jun;38(3):460-466.

Al-Harbi S, Hill BT, Mazumder S, Singh K, Devecchio J, Choudhary G, Rybicki LA, Kalaycio M, Maciejewski JP, Houghton JA, Almasan A. An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737. Blood. 2011 Sep 29;118(13):3579-3590.

Al-Marrawi MY, Rini B. Pazopanib for the treatment of renal cancer [Erratum in: Expert Opin Pharmacother. 2011 Jun;12(8):1349]. Expert Opin Pharmacother. 2011 May;12(7):1171-1189.

Albiges L, Salem M, Rini B, Escudier B. Vascular endothelial growth factor-targeted therapies in advanced renal cell carcinoma. Hematol Oncol Clin North Am. 2011 Aug;25(4):813-833.

Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, Kaplan ID, Wood DP, Ciezki J, Dunn RL, Carroll PR, Sanda MG. Prediction of erectile function following treatment for prostate cancer. JAMA. 2011 Sep 21;306(11):1205-1214.

Allen KL, Hamik A, Jain MK, McCrae KR. Endothelial cell activation by antiphospholipid antibodies is modulated by Kruppel-like transcription factors. Blood. 2011 Jun 9;117(23):6383-6391.

Alvarez A, Walsh D. Symptom control in advanced cancer: twenty principles. Am J Hosp Palliat Care. 2011 May;28(3):203-207.

Anderson BR, Muramatsu H, Jha BK, Silverman RH, Weissman D, Kariko K. Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L. Nucleic Acids Res. 2011 Nov 1;39(21):9329-9338.

Aron M, Zhou M. Merkel cell carcinoma of the genitourinary tract. Arch Pathol Lab Med. 2011 Aug;135(8):1067-1071.

Arora M, Klein JP, Weisdorf DJ, Hassebroek A, Flowers MED, Cutler CS, Urbano-Ispizua A, Antin JH, Bolwell BJ, Boyiadzis M, Cahn JY, Cairo MS, Isola L, Jacobsohn DA, Jagasia M, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman S, Wingard JR, Horowitz MM, Pavletic SZ. Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis. Blood. 2011 Jun 16;117(24):6714-6720.

Askar M, Sobecks R, Morishima Y, Kawase T, Nowacki A, Makishima H, Maciejewski J. Predictions in the face of clinical reality: HistoCheck versus high-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease. Biol Blood Marrow Transplant. 2011 Sep;17(9):1409-1415.

Avalos BR, Lazaryan A, Copelan EA. Can G-CSF cause leukemia in hematopoietic stem cell donors? Biol Blood Marrow Transplant. 2011 Dec;17(12):1739-1746.

Aziz N, Sharma RK, Mahfouz R, Jha R, Agarwal A. Association of sperm morphology and the sperm deformity index (SDI) with poly (ADP-ribose) polymerase (PARP) cleavage inhibition. Fertil Steril. 2011 Jun 30;95(8):2481-2484.

Babsky AM, Ju S, George B, Bennett S, Huang M, Jayaram HN, McLennan G, Bansal N. Predicting response to benzamide riboside chemotherapy in hepatocellular carcinoma using apparent diffusion coefficient of water. Anticancer Res. 2011 Jun;31(6):2045-2051.

Bailey DE, Jr., Wallace M, Latini DM, Hegarty J, Carroll PR, Klein EA, Albertsen PC. Measuring illness uncertainty in men undergoing active surveillance for prostate cancer. Appl Nurs Res. 2011 Nov;24(4):193-199.

Balzar S, Fajt ML, Comhair SAA, Erzurum SC, Bleecker E, Busse WW, Castro M, Gaston B, Israel E, Schwartz LB, Curran-Everett D, Moore CG, Wenzel SE. Mast cell phenotype, location, and activation in severe asthma: data from the severe asthma research program. Am J Respir Crit Care Med. 2011 Feb 1;183(3):299-309.

Barnett GH. Response [Evoked potentials]. J Neurosurg. 2011 Dec;115(6):1274.

Bartholomew JR, Schaffer JL, McCormick GF. Air travel and venous thromboembolism: Minimizing the risk. Cleve Clin J Med. 2011 Feb;78(2):111-120.

Bartholomew JR, Schaffer JL, McCormick GF. Air travel and venous thromboembolism: minimizing the risk [Republished from Cleve Clin J Med. 2011 Feb;78(2):111-120]. Minn Med. 2011 Jun;94(6):43-49.

Barykova YA, Logunov DY, Shmarov MM, Vinarov AZ, Fiev DN, Vinarova NA, Rakovskaya IV, Baker PS, Shyshynova I, Stephenson AJ, Klein EA, Naroditsky BS, Gintsburg AL, Gudkov AV. Association of Mycoplasma hominis infection with prostate cancer. Oncotarget. 2011 Apr;2(4):289-297.

Basappa NS, Elson P, Golshayan AR, Wood L, Garcia JA, Dreicer R, Rini BI. The impact of tumor burden characteristics in patients with metastatic renal cell carcinoma treated with sunitinib. Cancer. 2011 Mar 15;117(6):1183-1189.

Bauer EM, Zheng H, Comhair S, Erzurum S, Billiar TR, Bauer PM. Complement C3 deficiency attenuates chronic hypoxia-induced pulmonary hypertension in mice. PLoS ONE. 2011;6(12):e28578.

Bebek G, Orloff M, Eng C. Microenvironmental genomic alterations reveal signaling networks for head and neck squamous cell carcinoma. J Clin Bioinforma. 2011;1(1):21.

Bego MG, Keyes LR, Maciejewski J, St Jeor SC. Human cytomegalovirus latency-associated protein LUNA is expressed during HCMV infections in vivo. Arch Virol. 2011 Oct;156(10):1847-1851.

Bencsath KP, Reu F, Dietz J, Hsi ED, Heresi GA. Idiopathic systemic capillary leak syndrome preceding diagnosis of infiltrating lobular carcinoma of the breast with quiescence during neoadjuvant chemotherapy. Mayo Clin Proc. 2011 Mar;86(3):260-261.

Bennani-Baiti N, Daw HA. Primary hyperfibrinolysis in liver disease: a critical review. Clin Adv Hematol Oncol. 2011 Mar;9(3):250-252.

Bennani-Baiti N, Daw HA, Cotta C, Martin P, Mitchell KW, Ambinder RF, Macklis R, Pollock R, Spiro T. Low-grade follicular lymphoma of the small intestine: a challenge for management. Semin Oncol. 2011 Dec;38(6):714-720.

Bennani-Baiti N, Walsh D. Animal models of the cancer anorexia-cachexia syndrome. Support Care Cancer. 2011 Sep;19(9):1451-1463.

Bennett KL, Campbell R, Ganapathi S, Zhou M, Rini B, Ganapathi R, Neumann HPH, Eng C. Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinoma. Genes Chromosomes Cancer. 2011 Aug;50(8):654-661.

Beriwal S, Macklis RM, Basu S. Preface: Radiation therapy planning with PET. PET Clin. 2011 Apr;6(2):xi.

Bie B, Brown DL, Naguib M. Increased synaptic GluR1 subunits in the anterior cingulate cortex of rats with peripheral inflammation. Eur J Pharmacol. 2011 Feb 25;653(1-3):26-31.

Bie B, Brown DL, Naguib M. Synaptic plasticity and pain aversion. Eur J Pharmacol. 2011 Sep 30;667(1-3):26-31.

Bilotti E, Faiman BM, Richards TA, Tariman JD, Miceli TS, Rome SI. Survivorship care guidelines for patients living with multiple myeloma. Clin J Oncol Nurs. 2011 Aug;15(Suppl):5-8.

Bodo J, Hsi ED. Phosphoproteins and the dawn of functional phenotyping. Pathobiology. 2011;78(2):115-121.

Bodo J, Hsi ED. Selection and validation of antibodies for signal transduction immunohistochemistry. Methods Mol Biol. 2011;717:45-53.

Bodo J, Sedlak J, Maciejewski JP, Almasan A, Hsi ED. HDAC inhibitors potentiate the apoptotic effect of enzastaurin in lymphoma cells. Apoptosis. 2011 Sep;16(9):914-923.

Borden EC, Jacobs B, Hollovary E, Rybicki L, Elson P, Olencki T, Triozzi P. Gene regulatory and clinical effects of interferon beta in patients with metastatic melanoma: a phase II trial. J Interferon Cytokine Res. 2011 May;31(5):433-440.

Borden EC, Williams BR. Interferon-stimulated genes and their protein products: what and how? J Interferon Cytokine Res. 2011 Jan;31(1):1-4.

Bose A, Taylor JL, Alber S, Watkins SC, Garcia JA, Rini BI, Ko JS, Cohen PA, Finke JH, Storkus WJ. Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination. Int J Cancer. 2011 Nov 1;129(9):2158-2170.

Boyce SW, Bandyk DF, Bartholomew JR, Frame JN, Rice L. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT study. Am J Ther. 2011 Jan;18(1):14-22.

Brady AK, Fu AZ, Earl M, Kalaycio M, Advani A, Saunthararajah Y, Sobecks R, Copelan E, Sekeres MA. Race and intensity of post-remission therapy in acute myeloid leukemia. Leuk Res. 2011 Mar;35(3):346-350.

Brown DL. Using an anesthesia information management system to improve case log data entry and resident workflow. Anesth Analg. 2011 Feb;112(2):260-261.

Brown DL, Rockoff MA. Certification in sleep medicine. Anesthesiology. 2011 Jul;115(1):217.

Bukowski RM. Critical appraisal of pazopanib as treatment for patients with advanced metastatic renal cell carcinoma. Cancer Manag Res. 2011;3:273-285.

Bukowski RM. Biomarkers in renal cell carcinoma: what next? Curr Oncol Rep. 2011 Apr;13(2):87-89.

Bukowski RM. Renal cell carcinoma: Immunotherapy revisited. Therapy. 2011;8(4):335-338.

Burdick MJ, Neumann D, Pohlman B, Reddy CA, Tendulkar RD, Macklis R. External beam radiotherapy followed by (90)y ibritumomab tiuxetan in relapsed or refractory bulky follicular lymphoma. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1124-1130.

Busse WW, Peters SP, Fenton MJ, Mitchell H, Bleecker ER, Castro M, Wenzel S, Erzurum SC, Fitzpatrick AM, Teague WG, Jarjour N, Moore WC, Sumino K, Simeone S, Ratanamaneechat S, Penugonda M, Gaston B, Ross TM, Sigelman S, Schiepan JR, Zaccaro DJ, Crevar CJ, Carter DM, Togias A. Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine. J Allergy Clin Immunol. 2011 Jan;127(1):130-137.e3.

Calabrese C, Faiman B, Martin D, Reu F, Calabrese LH. Type 1 cryoglobulinemia: response to thalidomide and lenalidomide. J Clin Rheumatol. 2011 Apr;17(3):145-147.

Caloglu M, Ciezki JP, Reddy CA, Angermeier K, Ulchaker J, Chehade N, Altman A, Magi-Galuzzi C, Klein EA. PSA bounce and biochemical failure after brachytherapy for prostate cancer: A study of 820 patients with a minimum of 3 years of follow-up. Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):735-741.

Campbell SC. Editorial comment [Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma]. Urology. 2011 Jun;77(6):1397-1398.

Campbell SC, Lee B. Management of small renal masses: Donating kidneys to your local pathologist is not advised. Emerging Cancer Therapeutics. 2011;2(1):57-72.

Campbell SC, Palese MA. Laparoscopic cryoablation for a 3 cm nonhilar renal tumor. J Urol. 2011 Jan;185(1):14-16.

Castro M, Fain SB, Hoffman EA, Gierada DS, Erzurum SC, Wenzel S. Lung imaging in asthmatic patients: The picture is clearer. J Allergy Clin Immunol. 2011 Sep;128(3):467-478.

Cata JP, Klein EA, Hoeltge GA, Dalton JE, Mascha E, O'Hara J, Russell A, Kurz A, Ben-Elihayhu S, Sessler DI. Blood storage duration and biochemical recurrence of cancer after radical prostatectomy. Mayo Clin Proc. 2011 Feb;86(2):120-127.

Chakrabarti A, Jha BK, Silverman RH. New insights into the role of RNase L in innate immunity. J Interferon Cytokine Res. 2011 Jan;31(1):49-57.

Chan ER, Hester J, Kalady M, Xiao H, Li X, Serre D. A novel method for determining microflora composition using dynamic phylogenetic analysis of 16S ribosomal RNA deep sequencing data. Genomics. 2011 Oct;98(4):253-259.

Chan ESY, Patel AR, Larchian WA, Heston WD. In vivo targeted contrast enhanced micro-ultrasound to measure intratumor perfusion and vascular endothelial growth factor receptor 2 expression in a mouse orthotopic bladder cancer model. J Urol. 2011 Jun;185(6):2359-2365.

Chao ST, Kobayashi T, Benzel E, Reddy CA, Stevens GHJ, Prayson RA, Kalfas I, Schlenk R, Krishnaney A, Steinmetz MP, Bingaman W, Hahn J, Suh JH. The role of adjuvant radiation therapy in the treatment of spinal myxopapillary ependymomas. J Neurosurg Spine. 2011 Jan;14(1):59-64.

Chao ST, Angermeier K, Klein EA, Reddy CA, Ulchaker JC, Stephenson A, Campbell S, Ciezki JP. Prophylactic urethral stenting with memokath-« 028SW in prostate cancer patients undergoing prostate 125I seed implants: Phase I/II study. Journal of Contemporary Brachytherapy. 2011;3(1):18-22.

Chen K, Li W, Major J, Rahaman SO, Febbraio M, Silverstein RL. Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state. Blood. 2011 May 26;117(21):5744-5750.

Chen Y, Chen CF, Chiang HC, Pena M, Polci R, Wei RL, Edwards RA, Hansel DE, Chen PL, Riley DJ. Mutation of NIMA-related kinase 1 (NEK1) leads to chromosome instability. Mol Cancer. 2011;10(1):5.

Cheng L, Wu Q, Guryanova OA, Huang Z, Huang Q, Rich JN, Bao S. Elevated invasive potential of glioblastoma stem cells. Biochem Biophys Res Commun. 2011 Mar 25;406(4):643-648.

Cheriyath V, Kuhns MA, Kalaycio ME, Borden EC. Potentiation of apoptosis by histone deacetylase inhibitors and doxorubicin combination: cytoplasmic cathepsin B as a mediator of apoptosis in multiple myeloma. Br J Cancer. 2011 Mar 15;104(6):957-967.

Cheriyath V, Leaman DW, Borden EC. Emerging roles of FAM14 family members (G1P3/ISG 6-16 and ISG12/IFI27) in innate immunity and cancer. J Interferon Cytokine Res. 2011 Jan;31(1):173-181.

Ching CB, Amin MB, Tubbs RR, Elson P, Platt E, Dreicer R, Fergany A, Hansel DE. HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization. Mod Pathol. 2011 Aug;24(8):1111-1119.

Choueiri TK, Xie W, Kollmannsberger C, North S, Knox JJ, Lampard JG, McDermott DF, Rini BI, Heng DYC. The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy. J Urol. 2011 Jan;185(1):60-66.

Chu FM, Picus J, Fracasso PM, Dreicer R, Lang Z, Foster B. A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human alpha(v) integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancer. Invest New Drugs. 2011 Aug;29(4):674-679.

Chueh SCJ, Flechner S, Goldfarb D, Sankari BR, Campbell S. Re: Tollefson et al.: Surgical treatment of renal cell carcinoma in the immunocompromised transplant patient (Urology 2010;75:1373-1377). Urology. 2011 Jan;77(1):254-255.

Clemente MJ, Wlodarski MW, Makishima H, Viny AD, Bretschneider I, Shaik M, Bejanyan N, Lichtin AE, His ED, Paquette RL, Loughran TP, Jr., Maciejewski JP. Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia. Blood. 2011 Oct 20;118(16):4384-4393.

Cohen K, Ellis M, Khoury S, Davis PJ, Hercbergs A, Ashur-Fabian O. Thyroid hormone is a MAPK-dependent growth factor for human myeloma cells acting via {alpha}v{beta}3 integrin. Mol Cancer Res. 2011 Oct;9(10):1385-1394.

Comhair SAA, Gaston BM, Ricci KS, Hammel J, Dweik RA, Teague WG, Meyers D, Ampleford EJ, Bleecker ER, Busse WW, Calhoun WJ, Castro M, Chung KF, Curran-Everett D, Israel E, Jarjour WN, Moore W, Peters SP, Wenzel S, Hazen SL, Erzurum SC. Detrimental effects of environmental tobacco smoke in relation to asthma severity. PLoS ONE. 2011;6(5):e18574.

Costa R, Wesolowski R, Raghavan D. Chemotherapy for advanced adrenal cancer: improvement from a molecular approach? BJU Int. 2011 Nov;108(10):1546-1554.

Cotta CV, Coleman JF, Li S, Hsi ED. Nodular lymphocyte predominant Hodgkin lymphoma and diffuse large B-cell lymphoma: a study of six cases concurrently involving the same site. Histopathology. 2011 Dec;59(6):1194-1203.

Crane CH, Varadhachary GR, Yordy JS, Staerkel GA, Javle MM, Safran H, Haque W, Hobbs BD, Krishnan S, Fleming JB, Das P, Lee JE, Abbruzzese JL, Wolff RA. Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression. J Clin Oncol. 2011 Aug 1;29(22):3037-3043.

Cui X, Zeng F, Liu Y, Zhang J, Archacki S, Zhan T, Du R, Tang Z, Liu J, Wang QK, Liu M. A novel SCN1A missense mutation causes generalized epilepsy with febrile seizures plus in a Chinese family. Neurosci Lett. 2011 Sep 26;503(1):27-30.

Dabir S, Kluge A, Aziz MA, Houghton JA, Dowlati A. Identification of STAT3-independent regulatory effects for protein inhibitor of activated STAT3 by binding to novel transcription factors. Cancer Biol Ther. 2011 Jul 15;12(2):139-151.

Dada R, Mahfouz RZ, Kumar R, Venkatesh S, Shamsi MB, Agarwal A, Talwar P, Sharma RK. A comprehensive work up for an asthenozoospermic man with repeated intracytoplasmic sperm injection (ICSI) failure. Andrologia. 2011 Oct;43(5):368-372.

Daneshmand S, Stephenson AJ, Sheinfeld J, Jewett MAS. The management of subcentimeter residual mass in NSGCT: pcRPLND vs. observation. Urol Oncol. 2011 Nov-Dec;29(6):842-847.

Daud S, Hamrahian AH, Weil RJ, Hamaty M, Prayson RA, Olansky L. Acromegaly with negative pituitary MRI and no evidence of ectopic source: the role of transphenoidal pituitary exploration? Pituitary. 2011 Dec;14(4):414-417.

Davis MP. Fentanyl for breakthrough pain: a systematic review. Expert Rev Neurother. 2011 Aug;11(8):1197-1216.

Davis MP. Reversal of cancer cachexia and wasting prolongs survival. J Pain Symptom Manage. 2011 Mar;41(3):656-657.

Davis MP, Kirkova J, Lagman R, Walsh D, Karafa M. Intolerance to mirtazapine in advanced cancer. J Pain Symptom Manage. 2011 Sep;42(3):e4-e7.

Davis MP. Opioid tolerance and hyperalgesia: Basic mechanisms and management in review. Prog Palliat Care. 2011 Mar;19(2):73-86.

Davis PJ, Lin HY, Mousa SA, Luidens MK, Hercbergs AA, Wehling M, Davis FB. Overlapping nongenomic and genomic actions of thyroid hormone and steroids. Steroids. 2011 Aug;76(9):829-833.

de Campos-Lobato LF, Stocchi L, Dietz DW, Lavery IC, Fazio VW, Kalady MF. Prone or lithotomy positioning during an abdominoperineal resection for rectal cancer results in comparable oncologic outcomes. Dis Colon Rectum. 2011 Aug;54(8):939-946.

de Campos-Lobato LF, Stocchi L, da Luz Moreira A, Geisler D, Dietz DW, Lavery IC, Fazio VW, Kalady MF. Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence. Ann Surg Oncol. 2011 Jun;18(6):1590-1598.

de Campos-Lobato LF, Geisler DP, da Luz Moreira A, Stocchi L, Dietz DW, Kalady MF. Response to Letter to the Editor: Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery. J Gastrointest Surg. 2011 Jul;15(7):1293.

de Campos-Lobato LF, Geisler DP, da Luz Moreira A, Stocchi L, Dietz D, Kalady MF. Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery. J Gastrointest Surg. 2011 Mar;15(3):444-450.

Decker I, Ghosh S, Comhair SA, Farha S, Tang WHW, Park M, Wang S, Lichtin AE, Erzurum SC. High levels of zinc-protoporphyrin identify iron metabolic abnormalities in pulmonary arterial hypertension. Clin Transl Sci. 2011 Aug;4(4):253-258.

Decker RH, Langer CJ, Rosenzweig KE, Chang JY, Gewanter RM, Ginsburg ME, Kong FM, Lally BE, Videtic GM, Movsas B. ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancer. Am J Clin Oncol. 2011 Oct;34(5):537-544.

Delahunt B, Sika-Paotonu D, Bethwaite PB, Jordan TW, Magi-Galluzzi C, Zhou M, Samaratunga H, Srigley JR. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence. Am J Surg Pathol. 2011 Aug;35(8):1134-1139.

Demerjian S, Campbell SC. Editorial comment [Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors]. Urology. 2011 Apr;77(4):786.

Deshmukh L, Meller N, Alder N, Byzova T, Vinogradova O. Tyrosine phosphorylation as a conformational switch: A case study of integrin beta3 cytoplasmic tail. J Biol Chem. 2011 Nov 25;286(47):40943-40953.

Devarajan J, Siyam AM, Alexopoulos AV, Weil R, Farag E. Non-convulsive status epilepticus in the postanesthesia care unit following meningioma excision. Can J Anaesth. 2011 Jan;58(1):68-73.

Devulder J, van Suijlekom H, van Dongen R, Diwan S, Mekhail N, Van Kleef M, Huygen F. 25. Ischemic pain in the extremities and Raynaud's phenomenon. Pain Pract. 2011 Sep-Oct;11(5):483-491.

Downs-Kelly E, Rubin BP. Gastrointestinal stromal tumors: molecular mechanisms and targeted therapies. Patholog Res Int. 2011;2011:708596.

Drake KM, Zygmunt D, Mavrakis L, Harbor P, Wang L, Comhair SA, Erzurum SC, Aldred MA. Altered microRNA processing in heritable pulmonary arterial hypertension: An important role for Smad-8. Am J Respir Crit Care Med. 2011 Dec 15;184(12):1400-1408.

Dreicer R, Moul JW. Conclusion [New data, new paradigms for treating patients with prostate cancer]. Urology. 2011 Nov;78(5 Suppl):S499.

Dreicer R, Bajorin DF, McLeod DG, Petrylak DP, Moul JW. New data, new paradigms for treating prostate cancer patients VI: Novel hormonal therapy approaches. Urology. 2011 Nov;78(5 Suppl):S494-S498.

Dreicer R, Gleave M, Kibel AS, Thrasher JB, Moul JW. Targeting the androgen receptor-theory and practice. Urology. 2011 Nov;78(5 Suppl):S482-S484.

Dreicer R, Garcia J, Hussain M, Rini B, Vogelzang N, Srinivas S, Somer B, Zhao YD, Kania M, Raghavan D. Oral enzastaurin in prostate cancer: A two-cohort phase II trial in patients with PSA progression in the non-metastatic castrate state and following docetaxel-based chemotherapy for castrate metastatic disease. Invest New Drugs. 2011 Dec;29(6):1441-1448.

Duong HK, Bolwell BJ, Rybicki L, Koo A, Hsi ED, Figueroa P, Dean R, Pohlman B, Kalaycio M, Andresen S, Sobecks R, Copelan E. Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: A simple method using day 1 CD34+ cell yield. J Clin Apher. 2011;26(3):111-115.

Duong HT, Erzurum SC, Asosingh K. Pro-angiogenic hematopoietic progenitor cells and endothelial colony-forming cells in pathological angiogenesis of bronchial and pulmonary circulation. Angiogenesis. 2011 Dec;14(4):411-422.

Duong HT, Comhair SA, Aldred MA, Mavrakis L, Savasky BM, Erzurum SC, Asosingh K. Pulmonary artery endothelium resident endothelial colony-forming cells in pulmonary arterial hypertension. Pulm Circ. 2011 Oct;1(4):475-486.

Dweik RA, Erzurum SC. Update on pulmonary vascular diseases 2010. Am J Respir Crit Care Med. 2011 Jul 1;184(1):26-31.

Ebrahem Q, Qi JH, Sugimoto M, Ali M, Sears JE, Cutler A, Khokha R, Vasanji A, Anand-Apte B. Increased neovascularization in mice lacking tissue inhibitor of metalloproteinases-3. Invest Ophthalmol Vis Sci. 2011;52(9):6117-6123.

Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, Feng Z, Wood DP, Eastham JA, Yossepowitch O, Rabah DM, Kattan MW, Yu C, Klein EA, Stephenson AJ. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol. 2011 Mar;185(3):869-875.

Elbahesh H, Jha BK, Silverman RH, Scherbik SV, Brinton MA. The Flv(r)-encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cells. Virology. 2011 Jan 20;409(2):262-270.

Eng C. Something old, something new. Endocr Relat Cancer. 2011;18(1):E1.

Ergin AB, Cristofanilli M, Daw H, Tahan G, Gong Y. Recurrent granulomatous mastitis mimicking inflammatory breast cancer. BMJ Case Rep. 2011.

Espana EM, Levine M, Schoenfield L, Singh AD. Ocular surface squamous neoplasia in an anophthalmic socket 60 years after enucleation. Surv Ophthalmol. 2011 Nov-Dec;56(6):539-543.

Estfan B. Essential drugs in supportive care. Semin Oncol. 2011 Jun;38(3):413-423.

Eyler CE, Wu Q, Yan K, Macswords JM, Chandler-Militello D, Misuraca KL, Lathia JD, Forrester MT, Lee J, Stamler JS, Goldman SA, Bredel M, McLendon RE, Sloan AE, Hjelmeland AB, Rich JN. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell. 2011 Jul 8;146(1):53-66.

Faiman B. Overview and experience of a nursing e-mentorship program. Clin J Oncol Nurs. 2011 Aug 1;15(4):418-423.

Faiman BM, Mangan P, Spong J, Tariman JD. Renal complications in multiple myeloma and related disorders. Clin J Oncol Nurs. 2011 Aug 1;15:66-76.

Falzarano SM, Zhou M, Carver P, Tsuzuki T, Simmerman K, He H, Magi-Galluzzi C. ERG gene rearrangement status in prostate cancer detected by immunohistochemistry. Virchows Arch. 2011 Oct;459(4):441-447.

Falzarano SM, Zhou M, Hernandez AV, Klein EA, Rubin MA, Magi-Galluzzi C. Single focus prostate cancer: Pathological features and ERG fusion status. J Urol. 2011 Feb;185(2):489-494.

Falzarano SM, Magi-Galluzzi C. Prostate cancer staging and grading at radical prostatectomy over time. Adv Anat Pathol. 2011 Mar;18(2):159-164.

Fan W, Tang Z, Yin L, Morrison B, Hafez-Khayyata S, Fu P, Huang H, Bagai R, Jiang S, Kresak A, Howell S, Vasanji A, Flask CA, Halmos B, Koon H, Ma PC. MET-independent lung cancer cells evading EGFR kinase inhibitors are therapeutically susceptible to BH3 mimetic agents. Cancer Res. 2011 Jul 1;71(13):4494-4505.

Farag SS, Maharry K, Zhang MJ, Perez WS, George SL, Mrozek K, DiPersio J, Bunjes DW, Marcucci G, Baer MR, Cairo M, Copelan E, Cutler CS, Isola L, Lazarus HM, Litzow MR, Marks DI, Ringden O, Rizzieri DA, Soiffer R, Larson RA, Tallman MS, Bloomfield CD, Weisdorf DJ. Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission. Biol Blood Marrow Transplant. 2011 Dec;17(12):1796-1803.

Farha S, Asosingh K, Xu W, Sharp J, George D, Comhair S, Park M, Tang WHW, Loyd JE, Theil K, Tubbs R, Hsi E, Lichtin A, Erzurum SC. Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities. Blood. 2011 Mar 31;117(13):3485-3493.

Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco

P, Walsh D, Wilcock A, Kaasa S, Baracos VE. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011 May;12(5):489-495.

Feng W, Madajka M, Kerr BA, Mahabeleshwar GH, Whiteheart SW, Byzova TV. A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing. Blood. 2011 Apr 7;117(14):3893-3902.

Feng X, Scheinberg P, Wu CO, Samsel L, Nunez O, Prince C, Ganetzky RD, McCoy JP, Jr., Maciejewski JP, Young NS. Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes. Haematologica. 2011 Apr;96(4):602-606.

Feng Y, Ma PC. Anti-MET targeted therapy has come of age: the first durable complete response with MetMAb in metastatic gastric cancer. Cancer Discov. 2011 Dec;1(7):550-554.

Feng Y, Ma PC. Anti-MET targeted therapy has come of age: The first durable complete response with MetMAb in metastatic gastric cancer. Cancer Discov. 2011 Dec;1(7):550-554.

Finke J, Ko J, Rini B, Rayman P, Ireland J, Cohen P. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy. Int Immunopharmacol. 2011 Jul;11(7):856-861.

Fitzpatrick JM, Bellmunt J, Dreicer R, Fleshner NE, Logothetis CJ, Moul JW, Tombal B, Zlotta A. Maximizing outcomes in genitourinary cancers across the treatment continuum. BJU Int. 2011 Apr;107 Suppl 2:1-12.

Ford AC, Achkar JP, Khan KJ, Kane SV, Talley NJ, Marshall JK, Moayyedi P. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr;106(4):601-616.

Ford AC, Kane SV, Khan KJ, Achkar JP, Talley NJ, Marshall JK, Moayyedi P. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr;106(4):617-629.

Forrester MT, Eyler CE, Rich JN. Bacterial flavohemoglobin: a molecular tool to probe mammalian nitric oxide biology. Biotechniques. 2011 Jan;50(1):41-45.

Fox BA, Schendel DJ, Butterfield LH, Aamdal S, Allison JP, Ascierto PA, Atkins MB, Bartunkova J, Bergmann L, Berinstein N, Bonorino CC, Borden E, Bramson JL, Britten CM, Cao X, Carson WE, Chang AE, Characiejus D, Choudhury AR, Coukos G, de Gruijl T, Dillman RO, Dolstra H, Dranoff G, Durrant LG, Finke JH, Galon J, Gollob JA, Gouttefangeas C, Grizzi F, Guida M, Hakansson L, Hege K, Herberman RB, Hodi FS, Hoos A, Huber C, Hwu P, Imai K, Jaffee EM, Janetzki S, June CH, Kalinski P, Kaufman HL, Kawakami K, Kawakami Y, Keilholtz U, Khleif SN, Kiessling R, Kotlan B, Kroemer G, Lapointe R, Levitsky HI, Lotze MT, Maccalli C, Maio M, Marschner JP, Mastrangelo MJ, Masucci G, Melero I, Nelief C, Murphy WJ, Nelson B, Nicolini A, Nishimura MI, Odunsi K, Ohashi PS, O'Donnell-Tormey J, Old LJ, Ottensmeier C, Papamichail M, Parmiani G, Pawelec G, Proietti E, Qin S, Rees R, Ribas A, Ridolfi R, Ritter G, Rivoltini L, Romero PJ, Salem ML, Scheper RJ, Seliger B, Sharma P, Shiku H, Singh-Jasuja H, Song W, Straten PT, Tahara H, Tian Z, van Der Burg SH, von Hoegen P, Wang E, Welters MJP,

Winter H, Withington T, Wolchok JD, Xiao W, Zitvogel L, Zwierzina H, Marincola FM, Gajewski TF, Wigginton JM, Disis ML. Defining the critical hurdles in cancer immunotherapy. J Transl Med. 2011 Dec 14;9(1):214.

Frank-Raue K, Rybicki LA, Erlic Z, Schweizer H, Winter A, Milos I, Toledo SPA, Toledo RA, Tavares MR, Alevizaki M, Mian C, Siggelkow H, Hufner M, Wohllk N, Opocher G, Dvorakova S, Bendlova B, Czetwertynska M, Skasko E, Barontini M, Sanso G, Vorlander C, Maia AL, Patocs A, Links TP, De Groot JW, Kerstens MN, Valk GD, Miehle K, Musholt TJ, Biarnes J, Damjanovic S, Muresan M, Wuster C, Fassnacht M, Peczkowska M, Fauth C, Golcher H, Walter MA, Pichl J, Raue F, Eng C, Neumann HPH. Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. Hum Mutat. 2011 Jan;32(1):51-58.

Frank SJ, Arterbery VE, Hsu ICJ, Abdel-Wahab M, Ciezki JP, Hahn NM, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y, Merrick G. American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer. Brachytherapy. 2011 Sep-Oct;10(5):357-362.

Fritchie K, Fisher C, Coindre JM, Lazar AJ, Rubin BP. A brief history and contemporary re-assessment of malignant fibrous histiocytoma: "fact or fancy". Diagn Histopathol. 2011 Aug;17(8):340-347.

Gallagher LM. The role of music therapy in palliative medicine and supportive care. Semin Oncol. 2011 Jun;38(3):403-406.

Galsky MD, Hahn NM, Rosenberg J, Sonpavde G, Hutson T, Oh WK, Dreicer R, Vogelzang N, Sternberg C, Bajorin DF, Bellmunt J. A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy. Lancet Oncol. 2011 Mar;12(3):211-214.

Galsky MD, Hahn NM, Rosenberg J, Sonpavde G, Hutson T, Oh WK, Dreicer R, Vogelzang N, Sternberg CN, Bajorin DF, Bellmunt J. Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy. J Clin Oncol. 2011 Jun 10;29(17):2432-2438.

Ganapathi RN, Bukowski RM. Predicting responses to sunitinib using single nucleotide polymorphisms: Progress and recommendations for future trials. Genome Med. 2011;3(12):79.

Gangopahyay A, Oran M, Bauer EM, Wertz JW, Comhair SA, Erzurum SC, Bauer PM. Bone morphogenetic protein receptor II is a novel mediator of endothelial nitric-oxide synthase activation. J Biol Chem. 2011 Sep 23;286(38):33134-33140.

Gao Y, Yang K, Xu S, Wang C, Liu J, Zhang Z, Yuan M, Luo X, Liu M, Wang QK, Liu JY. Identification of compound heterozygous mutations in GNPTG in three siblings of a Chinese family with mucolipidosis type III gamma. Mol Genet Metab. 2011 Jan;102(1):107-109.

Garcia JA, Hutson TE, Shepard D, Elson P, Dreicer R. Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer: Results from a phase 2 trial. Cancer. 2011 Feb 15;117(4):752-757.

Garcia JA, Mekhail T, Elson P, Triozzi P, Nemec C, Dreicer R, Bukowski RM, Rini BI. Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trial. BJU Int. 2011 Feb;107(4):562-570.

Garcia JA. Sipuleucel-T in patients with metastatic castration-resistant prostate cancer: An insight for oncologists. Ther Adv Med Oncol. 2011 Mar;3(2):101-108.

Garcia JA, Dreicer R. Immunotherapy in castration-resistant prostate cancer: integrating sipuleucel-T into our current treatment paradigm. Oncology (Williston Park). 2011 Mar;25(3):242-249.

Ghoneim IA, Miocinovic R, Stephenson AJ, Garcia JA, Gong MC, Campbell SC, Hansel DE, Fergany AF. Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder. Urology. 2011 Apr;77(4):867-870.

Ghosh A, Murugesan G, Chen K, Zhang L, Wang Q, Febbraio M, Anselmo RM, Marchant K, Barnard J, Silverstein RL. Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms. Blood. 2011 Jun 9;117(23):6355-6366.

Ghosh PS, Ghosh D, Loddenkemper T, Prayson RA, Tekautz T, Sriram CS, Danziger-Isakov L. Necrotizing granulomatous meningoencephalitis due to Balamuthia in an immunocompetent child. Neurology. 2011 Aug 23;77(8):801-802.

Ghosh PS, D'Netto MA, Tekautz TM, Ghosh D. Congenital 'dumbbell' neuroblastoma presenting as paraplegia. J Paediatr Child Health. 2011 Dec;47(12):920.

Ghosh S, Erzurum SC. Nitric oxide metabolism in asthma pathophysiology. Biochim Biophys Acta. 2011 Nov;1810(11):1008-1016.

Gillet JP, Calcagno AM, Varma S, Marino M, Green LJ, Vora MI, Patel C, Orina JN, Eliseeva TA, Singal V, Padmanabhan R, Davidson B, Ganapathi R, Sood AK, Rueda BR, Ambudkar SV, Gottesman MM. Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance. Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18708-18713.

Gilligan T. The treatment of men with early-stage disease remains an area of significant controversy. Preface. Hematol Oncol Clin North Am. 2011 Jun;25(3):xiii-xxiv.

Gilligan T. Testicular cancer survivorship. Hematol Oncol Clin North Am. 2011 Jun;25(3):627-639.

Gilligan T. Preface [Testis cancer]. Hematol Oncol Clin North Am. 2011 Jun;25(3):xiii-xxiv.

Gilligan T. To better manage cancer symptoms. Cleve Clin J Med. 2011 Jan;78(1):24.

Gilligan T. Are we scanning testis cancer patients too often? Cancer. 2011 Sep 15;117(18):4108-4111.

Goc A, Choudhary M, Byzova TV, Somanath PR. TGFbeta- and bleomycin-induced extracellular matrix synthesis is mediated through Akt and mammalian target of rapamycin (mTOR). J Cell Physiol. 2011 Nov;226(11):3004-3013.

Goc A, Al-Husein B, Kochuparambil ST, Liu J, Heston WWD, Somanath PR. PI3 kinase integrates Akt and MAP kinase signaling pathways in the regulation of prostate cancer. Int J Oncol. 2011 Jan;38(1):267-277.

Gore E, Bae K, Langer C, Extermann M, Movsas B, Okunieff P, Videtic G, Choy H. Phase I/II trial of a cox-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: Radiation therapy oncology group 0213. Clin Lung Cancer. 2011 Mar;12(2):125-130.

Gromova P, Rubin BP, Thys A, Erneux C, Vanderwinden JM. Neurotensin receptor 1 is expressed in gastrointestinal stromal tumors but not in interstitial cells of cajal. PLoS ONE. 2011;6(2):e14710.

Grover V, Hamrahian AH, Prayson RA, Weil RJ. Rathke's cleft cyst presenting as bilateral abducens nerve palsy. Pituitary. 2011 Dec;14(4):395-399.

Grozav AG, Willard BB, Kozuki T, Chikamori K, Micluta MA, Petrescu AJ, Kinter M, Ganapathi R, Ganapathi MK. Tyrosine 656 in topoisomerase IIbeta is important for the catalytic activity of the enzyme: Identification based on artifactual +80-Da modification at this site. Proteomics. 2011 Mar;11(5):829-842.

Gulati S, Gustafson S, Daw HA. Lynch syndrome associated with PMS2 mutation: Understanding current concepts. Gastrointest Cancer Res. 2011 Sep;4(5-6):188-190.

Guryanova OA, Wu Q, Cheng L, Lathia JD, Huang Z, Yang J, MacSwords J, Eyler CE, McLendon RE, Heddleston JM, Shou W, Hambardzumyan D, Lee J, Hjelmeland AB, Sloan AE, Bredel M, Stark GR, Rich JN, Bao S. Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell. 2011 Apr 12;19(4):498-511.

Gustafson SL, Pfeiffer G, Eng C. A large health system's approach to utilization of the genetic counselor CPT(R) 96040 code. Genet Med. 2011 Dec;13(12):1011-1014.

Gutgsell TL. Commentary [Why oncologists should refer earlier for hospice care]. Oncology (Williston Park). 2011 Nov 30;25(13):1285.

Haddad A, Shepard D. Geriatric oncology and palliative medicine. Semin Oncol. 2011 Jun;38(3):362-366.

Hansel DE. Targeting melanoma: Endothelin B receptor makes an encore. Sci Transl Med. 2011;3(69):69ec17 .

Hansel DE, Paner GP, Nese N, Amin MB. Limited smoothelin expression within the muscularis mucosae: validation in bladder diverticula. Hum Pathol. 2011 Nov;42(11):1770-1776.

Harooni H, Schoenfield LR, Singh AD. Current appraisal of conjunctival melanocytic tumors: classification and treatment. Future Oncol. 2011 Mar;7(3):435-446.

Hayek SM, Veizi IE, Narouze SN, Mekhail N. Age-dependent intrathecal opioid escalation in chronic noncancer pain patients. Pain Med. 2011 Aug;12(8):1179-1189.

He H, Zhou GX, Zhou M, Chen L. The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray. Int J Gynecol Pathol. 2011 Sep;30(5):425-430.

He H, Magi-Galluzzi C, Li J, Carver P, Falzarano S, Smith K, Rubin MA, Zhou M. The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer". Am J Surg Pathol. 2011 Apr;35(4):608-614.

He X, Wang Y, Zhu J, Orloff M, Eng C. Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling. Cancer Lett. 2011 Feb 28;301(2):168-176.

He X, Ni Y, Wang Y, Romigh T, Eng C. Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53. Hum Mol Genet. 2011 Jan 1;20(1):80-89.

Heddleston JM, Hitomi M, Venere M, Flavahan WA, Yang K, Kim Y, Minhas S, Rich JN, Hjelmeland AB. Glioma stem cell maintenance: the role of the microenvironment. Curr Pharm Des. 2011;17(23):2386-2401.

Heng DYC, Xie W, Bjarnason GA, Vaishampayan U, Tan MH, Knox J, Donskov F, Wood L, Kollmannsberger C, Rini BI, Choueiri TK. Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy. Cancer. 2011 Jun 15;117(12):2637-2642.

Henkin RE, Del Rowe JD, Grigsby PW, Hartford AC, Jadvar H, Macklis RM, Parker JA, Wong JYC, Rosenthal SA. ACR-ASTRO practice guideline for the performance of therapy with unsealed radiopharmaceutical Sources. Clin Nucl Med. 2011 Aug;36(8):e72-e80.

Hercbergs AH, Lin HY, Davis FB, Davis PJ, Leith JT. Radiosensitization and production of DNA double-strand breaks in U87MG brain tumor cells induced by tetraiodothyroacetic acid (tetrac). Cell Cycle. 2011 Jan 15;10(2):352-357.

Herrstedt J, Walsh D. Introduction: Supportive care and palliative medicine. Semin Oncol. 2011 Jun;38(3):335-336.

Hill BT, Rybicki L, Bolwell BJ, Smith S, Dean R, Kalaycio M, Pohlman B, Tench S, Sobecks R, Andresen S, Copelan E, Sweetenham J. The non-relapse mortality rate for

patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls. Br J Haematol. 2011 Mar;152(5):561-569.

Hill BT, Rybicki L, Smith S, Dean R, Kalaycio M, Pohlman B, Sweetenham J, Tench S, Sobecks R, Andresen S, Copelan E, Bolwell BJ. Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma. Leuk Lymphoma. 2011 Jun;52(6):986-993.

Hjelmeland AB, Wu Q, Heddleston JM, Choudhary GS, MacSwords J, Lathia JD, McLendon R, Lindner D, Sloan A, Rich JN. Acidic stress promotes a glioma stem cell phenotype. Cell Death Differ. 2011 May;18(5):829-840.

Hjelmeland AB, Rich JN. Molecular targeting of neural cancer stem cells: TTAGGG, you're it! Clin Cancer Res. 2011 Jan 1;17(1):3-5.

Hjelmeland AB, Lathia JD, Sathornsumetee S, Rich JN. Twisted tango: brain tumor neurovascular interactions. Nat Neurosci. 2011;14(11):1375-1381.

Hoit BD, Dalton ND, Gebremedhin A, Janocha A, Zimmerman PA, Zimmerman AM, Strohl KP, Erzurum SC, Beall CM. Elevated pulmonary artery pressure among Amhara highlanders in Ethiopia. Am J Hum Biol. 2011 Mar-Apr;23(2):168-176.

Holguin F, Bleecker ER, Busse WW, Calhoun WJ, Castro M, Erzurum SC, Fitzpatrick AM, Gaston B, Israel E, Jarjour NN, Moore WC, Peters SP, Yonas M, Teague WG, Wenzel SE. Obesity and asthma: an association modified by age of asthma onset. J Allergy Clin Immunol. 2011 Jun;127(6):1486-1493.

Hood CT, Budd GT, Zakov ZN, Singh AD. Male breast carcinoma metastatic to the choroid: report of 3 cases and review of the literature. Eur J Ophthalmol. 2011 Jul-Aug;21(4):459-467.

Hosoyama T, Aslam MI, Abraham J, Prajapati SI, Nishijo K, Michalek JE, Zarzabal LA, Nelon LD, Guttridge DC, Rubin BP, Keller C. IL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcoma. Clin Cancer Res. 2011 May 1;17(9):2757-2766.

Hoyos M, Moore L, Williams PS, Zborowski M. The use of a linear Halbach array combined with a step-SPLITT channel for continuous sorting of magnetic species. J Magn Magn Mater. 2011 May 1;323(10):1384-1388.

Hsi ED, Tadmor T. Microenvironment in peripheral T cell lymphomas: macrophages and angiogenesis as targets. Leuk Lymphoma. 2011 Jan;52(1):3-4.

Hsi ED, Lorsbach RB, Fend F, Dogan A. Plasmablastic lymphoma and related disorders. Am J Clin Pathol. 2011 Aug;136(2):183-194.

Hsi LC, Kundu S, Palomo J, Xu B, Ficco R, Vogelbaum MA, Cathcart MK. Silencing IL-13R{alpha}2 promotes glioblastoma cell death via endogenous signaling. Mol Cancer Ther. 2011 Jul;10(7):1149-1160.

Hu Z, Gu X, Baraoidan K, Ibanez V, Sharma A, Kadkol S, Munker R, Ackerman S, Nucifora G, Saunthararajah Y. RUNX1 regulates corepressor interactions of PU.1. Blood. 2011 Jun 16;117(24):6498-6508.

Huang E, Rubin BP, Keller C. The long road to immunotherapy for childhood rhabdomyosarcoma. Pediatr Blood Cancer. 2011 Dec 1;57(6):899-901.

Huang Z, Wu Q, Guryanova OA, Cheng L, Shou W, Rich JN, Bao S. Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells. Nat Cell Biol. 2011 Feb;13(2):142-152.

Husseinzadeh HD, Garcia JA. Therapeutic rationale for mTOR inhibition in advanced renal cell carcinoma. Curr Clin Pharmacol. 2011 Aug 1;6(3):214-221.

Hussey GS, Chaudhury A, Dawson AE, Lindner DJ, Knudsen CR, Wilce MCJ, Merrick WC, Howe PH. Identification of an mRNP complex regulating tumorigenesis at the translational elongation step. Mol Cell. 2011 Feb 18;41(4):419-431.

Hutson TE, Bukowski RM, Cowey CL, Figlin R, Escudier B, Sternberg CN. Sequential use of targeted agents in the treatment of renal cell carcinoma. Crit Rev Oncol Hematol. 2011 Jan;77(1):48-62.

Induru RR, Lagman RL. Managing cancer pain: Frequently asked questions [Erratum in: Cleve Clin J Med. 2011 Dec;78(12):787]. Cleve Clin J Med. 2011 Jul;78(7):449-464.

Jacobsohn DA, Arora M, Klein JP, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Bolwell BJ, Antin JH, Boyiadzis M, Cahn JY, Cairo MS, Herzig RH, Isola LM, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman SR, Weisdorf DJ, Wingard JR, Horowitz MM, Pavletic SZ. Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease. Blood. 2011 Oct 20;118(16):4472-4479.

Jamshed S, Fowler DH, Neelapu SS, Dean RM, Steinberg SM, Odom J, Bryant K, Hakim F, Bishop MR. EPOCH-F: a novel salvage regimen for multiple myeloma before reduced-intensity allogeneic hematopoietic SCT. Bone Marrow Transplant. 2011 May;46(5):676-681.

Jankowska AM, Szpurka H, Calabro M, Mohan S, Schade AE, Clemente M, Silverstein RL, Maciejewski JP. Loss of expression of neutrophil proteinase-3: a factor contributing to thrombotic risk in paroxysmal nocturnal hemoglobinuria. Haematologica. 2011 Jul;96(7):954-962.

Jankowska AM, Makishima H, Tiu RV, Szpurka H, Huang Y, Traina F, Visconte V, Sugimoto Y, Prince C, O'Keefe C, Hsi ED, List A, Sekeres MA, Rao A, McDevitt MA, Maciejewski JP. Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. Blood. 2011 Oct 6;118(14):3932-3941.

Janocha AJ, Koch CD, Tiso M, Ponchia A, Doctor A, Gibbons L, Gaston B, Beall CM, Erzurum SC. Nitric oxide during altitude acclimatization. N Engl J Med. 2011 Nov 17;365(20):1942-1944.

Jarrar AM, Milas M, Mitchell J, Laguardia L, O'Malley M, Berber E, Siperstein A, Burke C, Church JM. Screening for thyroid cancer in patients with familial adenomatous polyposis. Ann Surg. 2011 Mar;253(3):515-521.

Jeremic B, Videtic GMM. Chest reirradiation with external beam radiotherapy for locally recurrent non-small-cell lung cancer: a review. Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):969-977.

Jha BK, Polyakova I, Kessler P, Dong B, Dickerman B, Sen GC, Silverman RH. Inhibition of RNase L and RNA-dependent protein kinase (PKR) by sunitinib impairs antiviral innate immunity. J Biol Chem. 2011 Jul 29;286(30):26319-26326.

John S, McCrae K. Catastrophic antiphospholipid syndrome in a patient with immune thrombocytopenic purpura. Uluslararasi Hematologi-Onkoloji Dergisi : UHOD [International Journal of Hematology and Oncology]. 2011;21(3):200-202.

Kalady MF, Jarrar A, Leach B, Laguardia L, O'Malley M, Eng C, Church JM. Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum. 2011 Feb;54(2):164-170.

Kalady MF, Church JM. Monitoring and management of desmoids and other extracolonic manifestations in familial adenomatous polyposis. Semin Colon Rectal Surg. 2011 Jun;22(2):112-117.

Kalady MF. Surgical management of hereditary nonpolyposis colorectal cancer. Adv Surg. 2011;45:265-274.

Kalaycio M, Bolwell B, Rybicki L, Absi A, Andresen S, Pohlman B, Dean R, Sobecks R, Copelan E. BU- vs TBI-based conditioning for adult patients with ALL. Bone Marrow Transplant. 2011 Nov;46(11):1413-1417.

Kaneshiro DK, Post JC, Rybicki L, Rice TW, Goldblum JR. Clinical significance of the duplicated muscularis mucosae in barrett esophagus-related superficial adenocarcinoma. Am J Surg Pathol. 2011 May;35(5):697-700.

Kang DE, Lee MC, Das Gupta J, Klein EA, Silverman RH. XMRV discovery and prostate cancer-related research. Adv Virol. 2011;2011:432837.

Karabulut K, Akyildiz HY, Lance C, Aucejo F, McLennan G, Agcaoglu O, Siperstein A, Berber E. Multimodality treatment of neuroendocrine liver metastases. Surgery. 2011 Aug;150(2):316-325.

Karam JA, Rini BI, Varella L, Garcia JA, Dreicer R, Choueiri TK, Jonasch E, Matin SF, Campbell SC, Wood CG, Tannir NM. Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma. J Urol. 2011 Feb;185(2):439-444.

Kasberg H, Brister L, Barnard B. Aggressive disease, aggressive treatment: the adult hematopoietic stem cell transplant patient in the intensive care unit. AACN Adv Crit Care. 2011 Oct;22(4):349-364.

Kasberg HL. "Dios bendiga usted!" "God bless you!". J Palliat Med. 2011 Jul;14(7):879-880.

Kavuru MS, Malur A, Marshall I, Barna BP, Meziane M, Huizar I, Dalrymple H, Karnekar R, Thomassen MJ. An open-label trial of rituximab therapy in pulmonary alveolar proteinosis. Eur Respir J. 2011 Dec;38(6):1361-1367.

Kawamoto T, Fan C, Gaivin RJ, Levine MA, Lietman SA. Decreased SH3BP2 inhibits osteoclast differentiation and function. J Orthop Res. 2011 Oct;29(10):1521-1527.

Kawsar HI, Spiro TP, Daw HA. Haematuria as an uncommon initial presenting symptom of metastatic squamous cell carcinoma (SCC) to kidney. BMJ Case Rep. 2011.

Kennedy DJ, Kuchibhotla S, Westfall KM, Silverstein RL, Morton RE, Febbraio M. A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling. Cardiovasc Res. 2011 Feb 15;89(3):604-613.

Khalil A, Spiotta AM, Barnett GH. Difficulties with the neurological assessment of humans following a chimpanzee attack. J Neurosurg. 2011 Jul;115(1):140-144.

Khan MIA, Walsh D, Brito-Dellan N. Opioid and adjuvant analgesics: compared and contrasted. Am J Hosp Palliat Care. 2011 Aug;28(5):378-383.

Khan MK, Khan N, Almasan A, Macklis R. Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents. Onco Targets Ther. 2011;4:137-148.

Khan N, Khan MK, Almasan A, Singh AD, Macklis R. The evolving role of radiation therapy in the management of malignant melanoma. Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):645-654.

Khan SN, Yennamalli R, Subbarao N, Khan AU. Mitoxantrone induced impediment of histone acetylation and structural flexibility of the protein. Cell Biochem Biophys. 2011 Jul;60(3):209-218.

Kikuchi K, Rubin BP, Keller C. Developmental origins of fusion-negative rhabdomyosarcomas. Curr Top Dev Biol. 2011;96:33-56.

Kim R, Menon N, Aucejo F. Safe use of sorafenib in a patient undergoing salvage liver transplantation for recurrent hepatocellular carcinoma after hepatic resection. Med Oncol. 2011 Dec;28(4):1044-1047.

Kim R, Tan A, Lai KK, Jiang J, Wang Y, Rybicki LA, Liu X. Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer. Cancer. 2011 Jul 15;117(14):3126-3134.

Kirkova J, Rybicki L, Walsh D, Aktas A, Davis MP, Karafa MT. The relationship between symptom prevalence and severity and cancer primary site in 796 patients with advanced cancer. Am J Hosp Palliat Care. 2011 Aug;28(5):350-355.

Kirkova J, Aktas A, Walsh D, Davis MP. Cancer symptom clusters: clinical and research methodology. J Palliat Med. 2011 Oct;14(10):1149-1166.

Klein EA, Thompson IM, Jr., Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL, Jr., Baker LH. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011 Oct 12;306(14):1549-1556.

Koh PK, Kalady M, Skacel M, Fay S, McGannon E, Shenal J, Arroyo L, Toderick K, Church J. Familial colorectal cancer type X: Polyp burden and cancer risk stratification via a family history score. ANZ J Surg. 2011 Jul-Aug;81(7-8):537-542.

Kojima S, Nakao S, Young N, Bacigalupo A, Gerard G, Hirano N, Maciejewski J, Deeg J, Marsh J, Zhang FK, Lee JW, Ozawa K. The Third Consensus Conference on the treatment of aplastic anemia. Int J Hematol. 2011 Jun;93(6):832-837.

Kollmannsberger C, Bjarnason G, Burnett P, Creel P, Davis M, Dawson N, Feldman D, George S, Hershman J, Lechner T, Potter A, Raymond E, Treister N, Wood L, Wu S, Bukowski R. Sunitinib in metastatic renal cell carcinoma: recommendations for management of noncardiovascular toxicities. Oncologist. 2011;16(5):543-553.

Komrokji RS, Sekeres MA, List AF. Management of lower-risk myelodysplastic syndromes:the art and evidence. Curr Hematol Malig Rep. 2011 Jun;6(2):145-153.

Kum JBJ, Grignon DJ, Wang M, Zhou M, Montironi R, Shen SS, Zhang S, Lopez-Beltran A, Eble JN, Cheng L. Mixed epithelial and stromal tumors of the kidney: evidence for a single cell of origin with capacity for epithelial and stromal differentiation. Am J Surg Pathol. 2011 Aug;35(8):1114-1122.

Kumar A, Figueroa PI, Gowans KL, Parker BM, Proctor AW, Benitez-Santana SM, Koch C. An evolution in blood management: past, present, and future. Qual Manag Health Care. 2011 Oct;20(4):311-321.

Kumaravel V, Hayden SP, Hall GS, Burke CA. New fecal occult blood tests may improve adherence and mortality rates. Cleve Clin J Med. 2011 Aug;78(8):515-520.

Lababede O, Meziane M, Rice T. Seventh edition of the cancer staging manual and stage grouping of lung cancer: quick reference chart and diagrams. Chest. 2011 Jan;139(1):183-189.

Lagman RL, Walsh D, LeGrand SB, Davis MP. The business of palliative medicine--part 6: clinical operations in a comprehensive integrated program. Am J Hosp Palliat Care. 2011 Mar;28(2):75-81.

Lamarre ED, Lorenz RR, Milstein C, Scharpf J. Laryngeal reinnervation after vagal paraganglioma resection: a case report. Am J Otolaryngol. 2011 Mar-Apr;32(2):171-173.

Lance C, McLennan G, Obuchowski N, Cheah G, Levitin A, Sands M, Spain J, Srinivas S, Shrikanthan S, Aucejo FN, Kim R, Menon KVN. Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90

radioembolization in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol. 2011 Dec;22(12):1697-1705.

Lane BR, Gill IS, Fergany AF, Larson BT, Campbell SC. Limited warm ischemia during elective partial nephrectomy has only a marginal impact on renal functional outcomes. J Urol. 2011 May;185(5):1598-1603.

Lane BR, Russo P, Uzzo RG, Hernandez AV, Boorjian SA, Thompson RH, Fergany AF, Love TE, Campbell SC. Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. J Urol. 2011 Feb;185(2):421-427.

Lanktree MB, Guo Y, Murtaza M, Glessner JT, Bailey SD, Onland-Moret NC, Lettre G, Ongen H, Rajagopalan R, Johnson T, Shen H, Nelson CP, Klopp N, Baumert J, Padmanabhan S, Pankratz N, Pankow JS, Shah S, Taylor K, Barnard J, Peters BJ, Maloney CM, Lobmeyer MT, Stanton A, Zafarmand MH, Romaine SPR, Mehta A, van Iperen EPA, Gong Y, Price TS, Smith EN, Kim CE, Li YR, Asselbergs FW, Atwood LD, Bailey KM, Bhatt D, Bauer F, Behr ER, Bhangale T, Boer JMA, Boehm BO, Bradfield JP, Brown M, Braund PS, Burton PR, Carty C, Chandrupatla HR, Chen W, Connell J, Dalgeorgou C, Boer A, Drenos F, Elbers CC, Fang JC, Fox CS, Frackelton EC, Fuchs B, Furlong CE, Gibson Q, Gieger C, Goel A, Grobbee DE, Hastie C, Howard PJ, Huang GH, Johnson WC, Li Q, Kleber ME, Klein BEK, Klein R, Kooperberg C, Ky B, LaCroix A, Lanken P, Lathrop M, Li M, Marshall V, Melander O, Mentch FD, Meyer J, Monda KL, Montpetit A, Murugesan G, Nakayama K, Nondahl D, Onipinla A, Rafelt S, Newhouse SJ, Otieno FG, Patel SR, Putt ME, Rodriguez S, Safa RN, Sawyer DB, Schreiner PJ, Simpson C, Sivapalaratnam S, Srinivasan SR, Suver C, Swergold G, Sweitzer NK, Thomas KA, Thorand B, Timpson NJ, Tischfield S, Tobin M, Tomaszweski M, Verschuren WMM, Wallace C, Winkelmann B, Zhang H, Zheng D, Zhang L, Zmuda JM, Clarke R, Balmforth AJ, Danesh J, Day IN, Schork NJ, de Bakker PIW, Delles C, Duggan D, Hingorani AD, Hirschhorn JN, Hofker MH, Humphries SE, Kivimaki M, Lawlor DA, Kottke-Marchant K, Mega JL, Mitchell BD, Morrow DA, Palmen J, Redline S, Shields DC, Shuldiner AR, Sleiman PM, Smith GD, Farrall M, Jamshidi Y, Christiani DC, Casas JP, Hall AS, Doevendans PA, Christie D, Berenson GS, Murray SS, Illig T, Dorn GW, Cappola TP, Boerwinkle E, Sever P, Rader DJ, Reilly MP, Caulfield M, Talmud PJ, Topol E, Engert JC, Wang K, Dominiczak A, Hamsten A, Curtis SP, Silverstein RL, Lange LA, Sabatine MS, Trip M, Saleheen D, Peden JF, Cruickshanks KJ, Marz W, O'Connell JR, Klungel OH, Wijmenga C, Maitland-van der Zee AH, Schadt EE, Johnson JA, Jarvik GP, Papanicolaou GJ, Grant SFA, Munroe PB, North KE, Samani NJ, Koenig W, Gaunt TR, Anand SS, van der Schouw YT, Soranzo N, FitzGerald GA, Reiner A, Hegele RA, Hakonarson H, Keating BJ. Meta-analysis of dense genecentric association studies reveals common and uncommon variants associated with height. Am J Hum Genet. 2011 Jan 7;88(1):6-18.

Lathia JD, Gallagher J, Myers JT, Li M, Vasanji A, McLendon RE, Hjelmeland AB, Huang AY, Rich JN. Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells. PLoS ONE. 2011;6(9):e24807.

Lathia JD, Hitomi M, Gallagher J, Gadani SP, Adkins J, Vasanji A, Liu L, Eyler CE, Heddleston JM, Wu Q, Minhas S, Soeda A, Hoeppner DJ, Ravin R, McKay RDG, McLendon RE, Corbeil D, Chenn A, Hjelmeland AB, Park DM, Rich JN. Distribution of

CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions. Cell Death Dis. 2011;2:e200.

Lathia JD, Heddleston JM, Venere M, Rich JN. Deadly teamwork: neural cancer stem cells and the tumor microenvironment. Cell Stem Cell. 2011 May 6;8(5):482-485.

Lathia JD, Venere M, Rao MS, Rich JN. Seeing is believing: Are cancer stem cells the Loch Ness monster of tumor biology? Stem Cell Rev. 2011 Jun;7(2):227-237.

Lazaryan A, Kalmadi S, Almhanna K, Pelley R, Kim R. Predictors of clinical outcomes of resected ampullary adenocarcinoma: A single-institution experience. Eur J Surg Oncol. 2011 Sep;37(9):791-797.

Lazoudis A, Kirova T, Ahmed EH, Qi P, Huennekens J, Lyyra AM. Electromagnetically induced transparency in an open V-type molecular system. Phys Rev A. 2011 Jun 27;83(6):063419.

Le Pechoux C, Laplanche A, Faivre-Finn C, Ciuleanu T, Wanders R, Lerouge D, Keus R, Hatton M, Videtic GM, Senan S, Wolfson A, Jones R, Arriagada R, Quoix E, Dunant A. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). Ann Oncol. 2011 May;22(5):1154-1163.

Lee BH, Hernandez AV, Zaytoun O, Berglund RK, Gong MC, Jones JS. Utility of percent free prostate-specific antigen in repeat prostate biopsy. Urology. 2011 Aug;78(2):386-391.

LeGrand SB. Modern management of malignant hypercalcemia. Am J Hosp Palliat Care. 2011 Nov;28(7):515-517.

Levi Z, Baris HN, Kedar I, Niv Y, Geller A, Gal E, Gingold R, Morgenstern S, Baruch Y, Leach BH, Bronner MP, Eng C. Upper and lower gastrointestinal findings in PTEN mutation-positive Cowden syndrome patients participating in an active surveillance program. Clin Transl Gastroenterol. 2011;2:e5.

Levis M, Ravandi F, Wang ES, Baer MR, Perl A, Coutre S, Erba H, Stuart RK, Baccarani M, Cripe LD, Tallman MS, Meloni G, Godley LA, Langston AA, Amadori S, Lewis ID, Nagler A, Stone R, Yee K, Advani A, Douer D, Wiktor-Jedrzejczak W, Juliusson G, Litzow MR, Petersdorf S, Sanz M, Kantarjian HM, Sato T, Tremmel L, Bensen-Kennedy DM, Small D, Smith BD. Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse. Blood. 2011 Mar 24;117(12):3294-3301.

Li C, Wang F, Yang Y, Fu F, Xu C, Shi L, Li S, Xia Y, Wu G, Cheng X, Liu H, Wang C, Wang P, Hao J, Ke Y, Zhao Y, Liu M, Zhang R, Gao L, Yu B, Zeng Q, Liao Y, Yang B, Tu X, Wang QK. Significant association of SNP rs2106261 in the ZFHX3 gene with atrial fibrillation in a Chinese Han GeneID population. Hum Genet. 2011 Mar;129(3):239-246.

Li J, Davis MP, Gamier P. Palliative medicine: Barriers and developments in mainland China. Curr Oncol Rep. 2011 Aug;13(4):290-294.

Li X, Howard TD, Moore WC, Ampleford EJ, Li H, Busse WW, Calhoun WJ, Castro M, Chung KF, Erzurum SC, Fitzpatrick AM, Gaston B, Israel E, Jarjour NN, Teague WG, Wenzel SE, Peters SP, Hawkins GA, Bleecker ER, Meyers DA. Importance of hedgehog interacting protein and other lung function genes in asthma. J Allergy Clin Immunol. 2011 Jun;127(6):1457-1465.

Liang R, Wallace AR, Schadendorf D, Rubin BP. The phosphatidyl inositol 3-kinase pathway is central to the pathogenesis of Kit-activated melanoma. Pigment Cell Melanoma Res. 2011 Aug;24(4):714-723.

Lichtin AE. Clinical practice guidelines for the use of erythroid-stimulating agents: ASCO, EORTC, NCCN. Cancer Treat Res. 2011;157:239-248.

Lietman SA. Preimplantation genetic diagnosis for hereditary endocrine disease. Endocr Pract. 2011 Jul-Aug;17 Suppl 3:28-32.

Lima BR, Schoenfield LR, Singh AD. The impact of intravitreal bevacizumab therapy on choroidal melanoma. Am J Ophthalmol. 2011 Feb;151(2):323-328.e2.

Limbach AL, Ni Y, Huang J, Eng C, Magi-Galluzzi C. Adenomatoid tumour of the adrenal gland in a patient with germline SDHD mutation: a case report and review of the literature. Pathology. 2011 Aug;43(5):495-498.

Lin HY, Cody V, Davis FB, Hercbergs AA, Luidens MK, Mousa SA, Davis PJ. Identification and functions of the plasma membrane receptor for thyroid hormone analogues. Discov Med. 2011 Apr;11(59):337-347.

Litle VR, Rice TW. The esophagus: do sex and gender matter? Semin Thorac Cardiovasc Surg. 2011;23(2):131-136.

Liu H, Liu W, Liao Y, Cheng L, Liu Q, Ren X, Shi L, Tu X, Wang QK, Guo AY. CADgene: a comprehensive database for coronary artery disease genes. Nucleic Acids Res. 2011 Jan;39(Database issue):D991-D996.

Liu L, Teague WG, Erzurum S, Fitzpatrick A, Mantri S, Dweik RA, Bleecker ER, Meyers D, Busse WW, Calhoun WJ, Castro M, Chung KF, Curran-Everett D, Israel E, Jarjour WN, Moore W, Peters SP, Wenzel S, Hunt JF, Gaston B. Determinants of exhaled breath condensate pH in a large population with asthma. Chest. 2011 Feb;139(2):328-336.

Ljungberg B, Campbell SC, Cho HY, Jacqmin D, Lee JE, Weikert S, Kiemeney LA. The epidemiology of renal cell carcinoma [Erratum in: Eur Urol. 2011 Dec;60(6):1317]. Eur Urol. 2011 Oct;60(4):615-621.

Loren AW, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S, Wang Z, Sobocinski KA, Gupta V, Hale GA, Marks DI, Stadtmauer EA, Apperley J, Cahn JY, Schouten HC, Lazarus HM, Savani BN, McCarthy PL, Jakubowski AA, Kamani NR, Hayes-Lattin B, Maziarz RT, Warwick AB, Sorror ML, Bolwell BJ, Socie G, Wingard JR, Rizzo JD,

Majhail NS. Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant. 2011 Feb;17(2):157-166.

Lorsbach RB, Hsi ED, Dogan A, Fend F. Plasma cell myeloma and related neoplasms. Am J Clin Pathol. 2011 Aug;136(2):168-182.

Lubejko B, Good M, Weiss P, Schmieder L, Leos D, Daugherty P. Oncology clinical trials nursing: developing competencies for the novice. Clin J Oncol Nurs. 2011 Dec;15(6):637-643.

Luthra P, Sun D, Silverman RH, He B. Activation of IFN-{beta} expression by a viral mRNA through RNase L and MDA5. Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2118-2123.

Lutz S, Berk L, Chang E, Chow E, Hahn C, Hoskin P, Howell D, Konski A, Kachnic L, Lo S, Sahgal A, Silverman L, von Gunten C, Mendel E, Vassil A, Bruner DW, Hartsell W. Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):965-976.

Ma DJ, Guo S, Shah SN, Srinivas SM, Macklis RM. The role of functional imaging in radiotherapy planning and management for gynecologic malignancies. PET Clin. 2011;6(2):195-205.

Mackenzie MJ, Rini BI, Elson P, Schwandt A, Wood L, Trinkhaus M, Bjarnason G, Knox J. Temsirolimus in VEGF-refractory metastatic renal cell carcinoma. Ann Oncol. 2011 Jan;22(1):145-148.

Macklis RM, Sharma N. Convergence technology in cancer medicine. Expert Rev Med Devices. 2011 Mar;8(2):263-273.

Magi-Galluzzi C, Tsusuki T, Elson P, Simmerman K, Lafargue C, Esgueva R, Klein E, Rubin MA, Zhou M. TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african-american and japanese patients. Prostate. 2011 Apr;71(5):489-497.

Magi-Galluzzi C, Evans AJ, Delahunt B, Epstein JI, Griffiths DF, van der Kwast TH, Montironi R, Wheeler TM, Srigley JR, Egevad LL, Humphrey PA. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. Mod Pathol. 2011 Jan;24(1):26-38.

Mahmoud FA, Aktas A, Walsh D, Hullihen B. A pilot study of taste changes among hospice inpatients with advanced cancer. Am J Hosp Palliat Care. 2011 Nov;28(7):487-492.

Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z, Horowitz MM, Bolwell B, Wingard JR, Socie G. Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. Blood. 2011 Jan 6;117(1):316-322.

Makin V, Hatipoglu B, Hamrahian AH, Arrossi AV, Knott PD, Lee JH, Sade B. Spontaneous cerebrospinal fluid rhinorrhea as the initial presentation of growth hormone-secreting pituitary adenoma. Am J Otolaryngol. 2011 Sep-Oct;32(5):433-437.

Makishima H, Maciejewski JP. Pathogenesis and consequences of uniparental disomy in cancer. Clin Cancer Res. 2011 Jun 15;17(12):3913-3923.

Makishima H, Jankowska AM, McDevitt MA, O'Keefe C, Dujardin S, Cazzolli H, Przychodzen B, Prince C, Nicoll J, Siddaiah H, Shaik M, Szpurka H, Hsi E, Advani A, Paquette R, Maciejewski JP. CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia. Blood. 2011 May 26;117(21):e198-e206.

Mali RS, Ramdas B, Ma P, Shi J, Munugalavadla V, Sims E, Wei L, Vemula S, Nabinger SC, Goodwin CB, Chan RJ, Traina F, Visconte V, Tiu RV, Lewis TA, Stern AM, Wen Q, Crispino JD, Boswell HS, Kapur R. Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABL. Cancer Cell. 2011 Sep 13;20(3):357-369.

Malik S, Bolwell B, Rybicki L, Copelan O, Duong H, Dean R, Sobecks R, Kalaycio M, Sweetenham J, Pohlman B, Andresen S, Tench S, Koo A, Figueroa P, Copelan E. Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantation. Bone Marrow Transplant. 2011 Dec;46(12):1519-1525.

Malinin NL, West XZ, Byzova TV. Oxidation as "the stress of life". Aging (Albany NY). 2011 Sep;3(9):906-910.

Mandawat A, Alraies MC, Miller K, Ondrejka S, Smith S. Cauda equina lymphoma: a case report including postmortem examination. Clin Adv Hematol Oncol. 2011 May;9(5):414-420.

Manola J, Royston P, Elson P, McCormack JB, Mazumdar M, Negrier S, Escudier B, Eisen T, Dutcher J, Atkins M, Heng DYC, Choueiri TK, Motzer R, Bukowski R. Prognostic model for survival in patients with metastatic renal cell carcinoma: results from the international kidney cancer working group. Clin Cancer Res. 2011 Aug 15;17(16):5443-5450.

Marina O, Suh JH, Chao ST. Response [Low Karnofsky Performance Scale score and glioblastoma multiforme]. J Neurosurg. 2011 Aug;115(2):218-219.

Marina O, Suh JH, Reddy CA, Barnett GH, Vogelbaum MA, Peereboom DM, Stevens GHJ, Elinzano H, Chao ST. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. J Neurosurg. 2011 Aug;115(2):220-229.

Marko NF, Suh JH, Chao ST, Barnett GH, Vogelbaum MA, Toms S, Weil RJ, Angelov L. Gamma knife stereotactic radiosurgery for the management of incidentally-identified brain metastasis from non-small cell lung cancer. J Neurooncol. 2011 Sep;104(3):817-824.

Marko NF, Weil RJ. Management of incidental pituitary tumors. Oncol Rev. 2011 Dec;5(4):233-239.

Marko NF, Weil RJ. Medical oncology: Patients with brain metastases in early-phase trials. Nat Rev Clin Oncol. 2011;8(7):390-391.

Marko NF, Weil RJ. A comparative effectiveness analysis of alternative strategies to assess hypothalamic-pituitary-adrenal axis function after microsurgical resection of pituitary tumors. Neurosurgery. 2011 Jun;68(6):1576-1585.

Marko NF, Quackenbush J, Weil RJ. Why is there a lack of consensus on molecular subgroups of glioblastoma? Understanding the nature of biological and statistical variability in glioblastoma expression data. PLoS ONE. 2011;6(7):e20826.

Marshall JR, Tangen CM, Sakr WA, Wood DP, Jr., Berry DL, Klein EA, Lippman SM, Parnes HL, Alberts DS, Jarrard DF, Lee WR, Gaziano JM, Crawford ED, Ely B, Ray M, Davis W, Minasian LM, Thompson IM, Jr. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila ). 2011 Nov;4(11):1761-1769.

Masucci GL, Yu E, Ma L, Chang EL, Letourneau D, Lo S, Leung E, Chao S, Hyde D, Gorgulho A, Muacevic A, Larson DA, Fehlings MG, Sahgal A. Stereotactic body radiotherapy is an effective treatment in reirradiating spinal metastases: current status and practical considerations for safe practice. Expert Rev Anticancer Ther. 2011 Dec;11(12):1923-1933.

Mazumdar T, Devecchio J, Agyeman A, Shi T, Houghton JA. Blocking hedgehog survival signaling at the level of the GLI genes induces DNA damage and extensive cell death in human colon carcinoma cells. Cancer Res. 2011 Sep 1;71(17):5904-5914.

Mazumdar T, Devecchio J, Agyeman A, Shi T, Houghton JA. The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer. Oncotarget. 2011 Aug;2(8):638-645.

Mazumdar T, Devecchio J, Shi T, Jones J, Agyeman A, Houghton JA. Hedgehog signaling drives cellular survival in human colon carcinoma cells. Cancer Res. 2011 Feb 1;71(3):1092-1102.

McCabe NP, Kerr BA, Madajka M, Vasanji A, Byzova TV. Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer. Neoplasia. 2011 Jan;13(1):31-39.

McCrae K. Immune thrombocytopenia: No longer 'idiopathic'. Cleve Clin J Med. 2011 Jun;78(6):358-373.

McCrae KR. Sutton's law and anti-{beta}2GPI antibodies. Blood. 2011 Mar 24;117(12):3253-3255.

McHaffie DR, Chabot P, Dagnault A, Suh JH, Fortin MA, Chang E, Timmerman R, Souhami L, Grecula J, Nabid A, Schultz C, Werner-Wasik M, Gaspar LE, Brachman D, Mody T, Mehta MP. Safety and feasibility of motexafin gadolinium administration with

whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of </=6 brain metastases: a multi-institutional phase II trial. J Neurooncol. 2011 Nov;105(2):301-308.

McLendon RE, Rich JN. Glioblastoma stem cells: A neuropathologist's view. J Oncol. 2011;2011:397195.

Megibow AJ, Baker ME, Gore RM, Taylor A. The incidental pancreatic cyst. Radiol Clin North Am. 2011 Mar;49(2):349-359.

Mekhail N, Wentzel DL, Freeman R, Quadri H. Counting the costs: case management implications of spinal cord stimulation treatment for failed back surgery syndrome. Prof Case Manag. 2011 Jan-Feb;16(1):27-36.

Mekhail N, Cheng J. Temperature mapping of cooled radiofrequency lesion of human cadaver thoracic facet medials Branches. Clin J Pain. 2011 Jan;27(1):56-60.

Mekhail NA, Mathews M, Nageeb F, Guirguis M, Mekhail MN, Cheng J. Retrospective review of 707 cases of spinal cord stimulation: indications and complications. Pain Pract. 2011 Mar-Apr;11(2):148-153.

Meng R, Tang HY, Westfall J, London D, Cao JH, Mousa SA, Luidens M, Hercbergs A, Davis FB, Davis PJ, Lin HY. Crosstalk between integrin alphavbeta3 and estrogen receptor-alpha is involved in thyroid hormone-induced proliferation in human lung carcinoma cells. PLoS ONE. 2011;6(11):e27547.

Mester JL, Tilot AK, Rybicki LA, Frazier TW, Eng C. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model. Eur J Hum Genet. 2011 Jul;19(7):763-768.

Meziane M, Obuchowski NA, Lababede O, Lieber ML, Philips M, Mazzone P. A comparison of follow-up recommendations by chest radiologists, general radiologists, and pulmonologists using computer-aided detection to assess radiographs for actionable pulmonary nodules. AJR Am J Roentgenol. 2011 May;196(5):W542-W549.

Miceli TS, Colson K, Faiman BM, Miller K, Tariman JD. Maintaining bone health in patients with multiple myeloma: Survivorship care plan of the international myeloma foundation nurse leadership board. Clin J Oncol Nurs. 2011 Aug;15(Suppl):9-23.

Mickelson DM, Sproat L, Dean R, Sobecks R, Rybicki L, Kalaycio M, Pohlman B, Sweetenham J, Andresen S, Bolwell B, Copelan EA. Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT. Bone Marrow Transplant. 2011 Jan;46(1):84-89.

Miocinovic R, Berglund RK, Stephenson AJ, Jones JS, Fergany A, Kaouk J, Klein EA. Reply by the authors [Re: Miocinovic et al.: Avoiding androgen deprivation therapy in men with high-risk prostate cancer: the role of radical prostatectomy as initial treatment (Urology 2011;77:946-950)]. Urology. 2011 Sep;78(3):725.

Miocinovic R, Berglund RK, Stephenson AJ, Jones JS, Fergany A, Kaouk J, Klein EA. Avoiding androgen deprivation therapy in men with high-risk prostate cancer: The role of radical prostatectomy as initial treatment. Urology. 2011 Apr;77(4):946-950.

Miocinovic R, Gong MC, Ghoneim IA, Fergany AF, Hansel DE, Stephenson AJ. Presacral and retroperitoneal lymph node involvement in urothelial bladder cancer: results of a prospective mapping study. J Urol. 2011 Oct;186(4):1269-1273.

Miocinovic R, Jones JS, Pujara AC, Klein EA, Stephenson AJ. Acceptance and durability of surveillance as a management choice in men with screen-detected, low-risk prostate cancer: improved outcomes with stringent enrollment criteria. Urology. 2011 Apr;77(4):980-984.

Moline J, Ngeow J, Rajiah P, Eng C. Evil lurks in the heart of man: Cardiac paraganglioma presenting as recurrent dyspnoea and chronic cough. BMJ Case Rep. 2011.

Moline J, Eng C. Multiple endocrine neoplasia type 2: An overview. Genet Med. 2011 Sep;13(9):755-764.

Montes-Moreno S, Martinez N, Sanchez-Espiridion B, Diaz Uriarte R, Rodriguez ME, Saez A, Montalban C, Gomez G, Pisano DG, Garcia JF, Conde E, Gonzalez-Barca E, Lopez A, Mollejo M, Grande C, Martinez MA, Dunphy C, Hsi ED, Rocque GB, Chang J, Go RS, Visco C, Xu-Monette Z, Young KH, Piris MA. miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy. Blood. 2011 Jul 28;118(4):1034-1040.

Moran BJ, DeRose P, Hsu ICJ, Abdel-Wahab M, Arterbery VE, Ciezki JP, Frank SJ, Mohler JL, Rosenthal SA, Rossi CJ, Jr., Yamada Y, Merrick GS. ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer. Am J Clin Oncol. 2011 Dec;34(6):636-647.

Morgensztern D, Pennell NA, Subramanian J, Govindan R. Summary of presentations from the 46th annual meeting of the american society of clinical oncology (2010): focus on developmental therapeutics related to lung cancer. Clin Lung Cancer. 2011 Mar;12(2):94-99.

Morris-Stiff G, Falk GA, Joyce D, Rubin B, Chalikonda S. Primary omental haemangiopericytoma. BMJ Case Rep. 2011.

Moul JW, Evans CP, Gomella LG, Roach M, III, Dreicer R. Traditional approaches to androgen deprivation therapy. Urology. 2011 Nov;78(5 Suppl):S485-S493.

Moul JW, Dreicer R. New data, new paradigms for treating patients with prostate cancer: introduction. Urology. 2011 Nov;78(5 Suppl):S475.

Moul JW, Kibel AS, Roach M, III, Dreicer R. Indications and practice with androgen deprivation therapy. Urology. 2011 Nov;78(5 Suppl):S478-S481.

Moul JW, Dreicer R. Focusing on testosterone. Urology. 2011 Nov;78(5 Suppl):S476-S477.

Mueller S, Polley MY, Lee B, Kunwar S, Pedain C, Wembacher-Schroder E, Mittermeyer S, Westphal M, Sampson JH, Vogelbaum MA, Croteau D, Chang SM. Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study. J Neurooncol. 2011 Jan;101(2):267-277.

Mulligan GB, Eray E, Faiman C, Gupta M, Pineyro MM, Makdissi A, Suh JH, Masaryk TJ, Prayson R, Weil RJ, Hamrahian AH. Reduction of false-negative results in inferior petrosal sinus sampling with simultaneous prolactin and corticotropin measurement. Endocr Pract. 2011 Jan-Feb;17(1):33-40.

Murphy ES, Barnett GH, Vogelbaum MA, Neyman G, Stevens GH, Cohen BH, Elson P, Vassil AD, Suh JH. Long-term outcomes of Gamma Knife radiosurgery in patients with vestibular schwannomas. J Neurosurg. 2011 Feb;114(2):432-440.

Murphy ES, Suh JH. Radiotherapy for vestibular schwannomas: a critical review. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):985-997.

Muslimani A, Chisti MM, Wills S, Nadeau L, Zakalik D, Daw H, Huang J, Jaiyesimi I. How we treat tumor lysis syndrome. Oncology (Williston Park). 2011 Apr 15;25(4):369-375.

Mutetwa B, Fryzek J, Du Y, Yong M, Sekeres MA, Taioli E. Baseline characteristics and predictors of outcome in patients with myelodysplastic syndromes living in Western Pennsylvania. Leuk Lymphoma. 2011 Feb;52(2):265-272.

Nagy R, Ganapathi S, Comeras I, Peterson C, Orloff M, Porter K, Eng C, Ringel MD, Kloos RT. Frequency of germline PTEN mutations in differentiated thyroid cancer. Thyroid. 2011 May;21(5):505-510.

Nakajima T, Mitsunaga M, Bander NH, Heston WD, Choyke PL, Kobayashi H. Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate. Bioconjug Chem. 2011 Aug 17;22(8):1700-1705.

Negrotto S, Hu Z, Alcazar O, Ng KP, Triozzi P, Lindner D, Rini B, Saunthararajah Y. Noncytotoxic differentiation treatment of renal cell cancer. Cancer Res. 2011 Feb 15;71(4):1431-1441.

Nemunaitis J, Senzer N, Cooper B, Nemunaitis M, Bedell C, Singer JW, Oldham FB. Procoagulant inhibitory properties of paclitaxel poliglumex. Int J Gen Med. 2011;4:5-11.

Neumann HPH, Sullivan M, Winter A, Malinoc A, Hoffmann MM, Boedeker CC, Bertz H, Walz MK, Moeller LC, Schmid KW, Eng C. Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites. J Clin Endocrinol Metab. 2011 Aug;96(8):E1279-E1282.

Newcomer AE, Dylinski D, Rubin BP, Joyce MJ, Hoeltge G, Bershadsky B, Lietman SA. Prognosticators in thigh soft tissue sarcomas. J Surg Oncol. 2011 Jan 1;103(1):85-91.

Ng KP, Ebrahem Q, Negrotto S, Mahfouz RZ, Link KA, Hu Z, Gu X, Advani A, Kalaycio M, Sobecks R, Sekeres M, Copelan E, Radivoyevitch T, Maciejewski J, Mulloy JC,

Saunthararajah Y. p53 independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia. Leukemia. 2011 Nov;25(11):1739-1750.

Ngeow J, Mester J, Rybicki LA, Ni Y, Milas M, Eng C. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations. J Clin Endocrinol Metab. 2011 Dec;96(12):E2063-E2071.

Nguyen CT, Stephenson AJ. Role of postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors. Hematol Oncol Clin North Am. 2011 Jun;25(3):593-604.

Ni Y, Eng C. Response to Bayley: functional study informs bioinformatic analysis. Am J Hum Genet. 2011 May 13;88(5):676.

Nicholson BP, Lystad LD, Emch TM, Singh AD. Idiopathic dural optic nerve sheath calcification. Br J Ophthalmol. 2011 Feb;95(2):290, 299.

O'Connor OA, Pro B, Pinter-Brown L, Bartlett N, Popplewell L, Coiffier B, Lechowicz MJ, Savage KJ, Shustov AR, Gisselbrecht C, Jacobsen E, Zinzani PL, Furman R, Goy A, Haioun C, Crump M, Zain JM, Hsi E, Boyd A, Horwitz S. Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: Results from the pivotal PROPEL study. J Clin Oncol. 2011 Mar 20;29(9):1182-1189.

O'Keefe CL, Sugimori C, Afable M, Clemente M, Shain K, Araten DJ, List A, Epling-Burnette PK, Maciejewski JP. Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuria. Leukemia. 2011 Feb;25(2):379-382.

Olivieri NF, Saunthararajah Y, Thayalasuthan V, Kwiatkowski J, Ware RE, Kuypers FA, Kim HY, Trachtenberg FL, Vichinsky EP. A pilot study of subcutaneous decitabine in beta-thalassemia intermedia. Blood. 2011 Sep 8;118(10):2708-2711.

Ondrejka SL, Lai R, Smith SD, Hsi ED. Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis. Haematologica. 2011 Aug;96(8):1121-1127.

Onlamoon N, Das Gupta J, Sharma P, Rogers K, Suppiah S, Rhea J, Molinaro RJ, Gaughan C, Dong B, Klein EA, Qiu X, Devare S, Schochetman G, Hackett J, Jr., Silverman RH, Villinger F. Infection, viral dissemination, and antibody responses of rhesus macaques exposed to the human gammaretrovirus XMRV. J Virol. 2011 May;85(9):4547-4557.

Ooi A, Wong JC, Petillo D, Roossien D, Perrier-Trudova V, Whitten D, Min BWH, Tan MH, Zhang Z, Yang XJ, Zhou M, Gardie B, Molinie V, Richard S, Tan PH, Teh BT, Furge KA. An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell. 2011 Oct 18;20(4):511-523.

Orloff M, Peterson C, He X, Ganapathi S, Heald B, Yang YR, Bebek G, Romigh T, Song JH, Wu W, David S, Cheng Y, Meltzer SJ, Eng C. Germline mutations in MSR1,

ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma. JAMA. 2011 Jul 27;306(4):410-419.

Overdevest JB, Thomas S, Kristiansen G, Hansel DE, Smith SC, Theodorescu D. CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization. Cancer Res. 2011 Jun 1;71(11):3802-3811.

Oya S, Sade B, Lee JH. Sphenoorbital meningioma: surgical technique and outcome. J Neurosurg. 2011 May;114(5):1241-1249.

Oya S, Sade B, Lee JH. Benefits and limitations of diameter measurement in the conservative management of meningiomas. Surg Neurol Int. 2011;2:158.

Oya S, Kim SH, Sade B, Lee JH. The natural history of intracranial meningiomas. J Neurosurg. 2011 May;114(5):1250-1256.

Pasquali T, Schoenfield L, Spalding SJ, Singh AD. Orbital inflammation in IgG4-related sclerosing disease. Orbit. 2011 Oct;30(5):258-260.

Patard JJ, Pignot G, Escudier B, Eisen T, Bex A, Sternberg C, Rini B, Roigas J, Choueiri T, Bukowski R, Motzer R, Kirkali Z, Mulders P, Bellmunt J. ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease. Eur Urol. 2011 Oct;60(4):684-690.

Patel AR, Lee BH, Campbell SC, Fergany AF, Zhou M. Reply [Bilateral synchronous sporadic renal tumors: pathologic concordance and clinical implications]. Urology. 2011 Nov;78(5):1099-1100.

Patel AR, Lee BH, Campbell SC, Zhou M, Fergany AF. Bilateral synchronous sporadic renal tumors: pathologic concordance and clinical implications. Urology. 2011 Nov;78(5):1095-1099.

Patel AR, Stephenson AJ. Radiation therapy for prostate cancer after prostatectomy: adjuvant or salvage? Nat Rev Urol. 2011;8(7):385-392.

Patijn J, Mekhail N, Hayek S, Lataster A, Van Kleef M, Van Zundert J. Meralgia paresthetica. Pain Pract. 2011 May-Jun;11(3):302-308.

Patijn J, Vallejo R, Janssen M, Huygen F, Lataster A, Van Kleef M, Mekhail N. Carpal tunnel syndrome. Pain Pract. 2011 May-Jun;11(3):297-301.

Patil DT, Rubin BP. Gastrointestinal stromal tumor: advances in diagnosis and management. Arch Pathol Lab Med. 2011 Oct;135(10):1298-1310.

Peerzada MM, Spiro TP, Daw HA. Pulmonary toxicities of tyrosine kinase inhibitors. Clin Adv Hematol Oncol. 2011 Nov;9(11):824-836.

Pennell NA. Integration of EGFR inhibitors and conventional chemotherapy in the treatment of non-small-cell lung cancer. Clin Lung Cancer. 2011 Nov;12(6):350-359.

Phull HS, Pan HQ, Butler RS, Hansel DE, Damaser MS. Vulnerability of continence structures to injury by simulated childbirth. Am J Physiol Renal Physiol. 2011 Sep;301(3):F641-F649.

Pluijms W, Huygen F, Cheng J, Mekhail N, Van Kleef M, Van Zundert J, van Dongen R. Evidence-based interventional pain medicine according to clinical diagnoses. 18. Painful diabetic polyneuropathy. Pain Pract. 2011 Mar-Apr;11(2):191-198.

Pluskota E, Dowling JJ, Gordon N, Golden JA, Szpak D, West XZ, Nestor C, Ma YQ, Bialkowska K, Byzova T, Plow EF. The integrin coactivator Kindlin-2 plays a critical role in angiogenesis in mice and zebrafish. Blood. 2011 May 5;117(18):4978-4987.

Powazki RD. The family conference in oncology: benefits for the patient, family, and physician. Semin Oncol. 2011 Jun;38(3):407-412.

Prajapati SI, Kilcoyne A, Samano AK, Green DP, McCarthy SD, Blackman BA, Brady MM, Zarzabal LA, Tatiparthy AK, Sledz TJ, Duong T, Ohshima-Hosoyama S, Giles FJ, Michalek JE, Rubin BP, Keller C. MicroCT-based virtual histology evaluation of preclinical medulloblastoma. Mol Imaging Biol. 2011 Jun;13(3):493-499.

Prayson NF, Koch P, Angelov L, Prayson RA. Microscopic thrombi in anaplastic astrocytoma predict worse survival? Ann Diagn Pathol. 2011 Dec;15(6):389-393.

Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R, Scheinberg P, Savage S, Maciejewski JP, Tiu RV, DiFronzo N, Horowitz MM, Antin JH. Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the blood and marrow transplant clinical trials network, march 2010. Biol Blood Marrow Transplant. 2011 Mar;17(3):291-299.

Punnen S, Hardin J, Cheng I, Klein EA, Witte JS. Impact of meat consumption, preparation, and mutagens on aggressive prostate cancer. PLoS ONE. 2011;6(11):e27711.

Puylaert M, Kapural L, Van Zundert J, Peek D, Lataster A, Mekhail N, Van Kleef M, Keulemans YCA. 26. Pain in chronic pancreatitis. Pain Pract. 2011 Sep-Oct;11(5):492-505.

Rahaman SO, Swat W, Febbraio M, Silverstein RL. Vav family Rho guanine nucleotide exchange factors regulate CD36-mediated macrophage foam cell formation. J Biol Chem. 2011 Mar 4;286(9):7010-7017.

Rahmathulla G, Barnett GH. Vestibular schwannoma of oscillating size: A case report and review of literature. Surg Neurol Int. 2011;2:187.

Raina R, Nadig V, Patel D, Jegalian A, Silver B, Heyka RJ. Spontaneous perinephric hematoma due to acquired factor X deficiency in AL amyloidosis. NDT Plus. 2011 Apr;4(2):101-103.

Raja S, Rice TW, Goldblum JR, Rybicki LA, Murthy SC, Mason DP, Blackstone EH. Esophageal submucosa: The watershed for esophageal cancer. J Thorac Cardiovasc Surg. 2011 Dec;142(6):1403-1411.

Raja S, Rice TW, Mason DP, Rodriguez C, Tan C, Rodriguez ER, Manno E, Videtic GM, Murthy SC. Fatal cerebral air embolus complicating multimodality treatment of esophageal cancer. Ann Thorac Surg. 2011 Nov;92(5):1901-1903.

Rao RD, Cobleigh MA, Gray R, Graham ML, Norton L, Martino S, Budd GT, Ingle JN, Wood WC. Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group. Med Oncol. 2011 Dec;28 Suppl 1:S39-S47.

Raychaudhuri B, Rayman P, Ireland J, Ko J, Rini B, Borden EC, Garcia J, Vogelbaum MA, Finke J. Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma. Neuro Oncol. 2011 Jun;13(6):591-599.

Raychaudhuri B, Vogelbaum MA. IL-8 is a mediator of NF-kappaB induced invasion by gliomas. J Neurooncol. 2011 Jan;101(2):227-235.

Reardon DA, Galanis E, DeGroot JF, Cloughesy TF, Wefel JS, Lamborn KR, Lassman AB, Gilbert MR, Sampson JH, Wick W, Chamberlain MC, Macdonald DR, Mehta MP, Vogelbaum MA, Chang SM, Van den Bent MJ, Wen PY. Clinical trial end points for high-grade glioma: the evolving landscape. Neuro Oncol. 2011 Mar;13(3):353-361.

Reardon DA, Vredenburgh JJ, Coan A, Desjardins A, Peters KB, Gururangan S, Sathornsumetee S, Rich JN, Herndon JE, Friedman HS. Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma. J Neurooncol. 2011 Dec;105(3):621-627.

Reardon DA, Desjardins A, Peters K, Gururangan S, Sampson J, Rich JN, McLendon R, Herndon JE, Marcello J, Threatt S, Friedman AH, Vredenburgh JJ, Friedman HS. Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy. J Neurooncol. 2011 Jun;103(2):371-379.

Ren B, Hale J, Srikanthan S, Silverstein RL. Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway. Blood. 2011 Jun 2;117(22):6036-6045.

Rice BL, Farver CF, Pohlman B, Burkey BB, Parambil JG. Concomitant Castleman's disease and sarcoidosis. Am J Med Sci. 2011 Mar;341(3):257-259.

Rice TW, Goldblum JR, Rybicki LA, Rajeswaran J, Murthy SC, Mason DP, Blackstone EH. Fate of the esophagogastric anastomosis. J Thorac Cardiovasc Surg. 2011 Apr;141(4):875-880.

Rice TW, Shay SS. A primer of high-resolution esophageal manometry. Semin Thorac Cardiovasc Surg. 2011;23(3):181-190.

Rice TW, Bronner MP. The esophageal wall. Thorac Surg Clin. 2011 May;21(2):299-305.

Rice TW, Murthy SC, Mason DP, Rybicki LA, Yerian LM, Dumot JA, Rodriguez CP, Blackstone EH. Esophagectomy for clinical high-grade dysplasia. Eur J Cardiothorac Surg. 2011 Jul;40(1):113-119.

Richendollar BG, Pohlman B, Elson P, Hsi ED. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma. Hum Pathol. 2011 Apr;42(4):552-557.

Rimm DL, Nielsen TO, Jewell SD, Rohrer DC, Broadwater G, Waldman F, Mitchell KA, Singh B, Tsongalis GJ, Frankel WL, Magliocco AM, Lara JF, Hsi ED, Bleiweiss IJ, Badve SS, Chen B, Ravdin PM, Schilsky RL, Thor A, Berry DA. Cancer and leukemia group B pathology committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues. J Clin Oncol. 2011 Jun 1;29(16):2282-2290.

Rini B. Kidney cancer: Does hypothyroidism predict clinical outcome? Nat Rev Urol. 2011 Jan;8(1):10-11.

Rini B, Al-Marrawi MY. Pazopanib for the treatment of renal cancer. Expert Opin Pharmacother. 2011 May;12(7):1171-1189.

Rini BI, Stein M, Shannon P, Eddy S, Tyler A, Stephenson JJ, Jr., Catlett L, Huang B, Healey D, Gordon M. Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma. Cancer. 2011 Feb 15;117(4):758-767.

Rini BI. Review: Thyroid function abnormalities in patients receiving VEGF-targeted therapy. Clin Adv Hematol Oncol. 2011 Apr;9(4):337-338.

Rini BI, Cohen DP, Lu DR, Chen I, Hariharan S, Gore ME, Figlin RA, Baum MS, Motzer RJ. Response [Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib]. J Natl Cancer Inst. 2011 Oct 19;103(20):1558.

Rini BI. Targeted therapy for patients with renal-cell carcinoma. Lancet Oncol. 2011 Nov;12(12):1085-1087.

Rini BI, Schiller JH, Fruehauf JP, Cohen EEW, Tarazi JC, Rosbrook B, Bair AH, Ricart AD, Olszanski AJ, Letrent KJ, Kim S, Rixe O. Diastolic blood pressure as a biomarker of axitinib efficacy in solid tumors. Clin Cancer Res. 2011 Jun 1;17(11):3841-3849.

Rini BI, Cohen DP, Lu DR, Chen I, Hariharan S, Gore ME, Figlin RA, Baum MS, Motzer RJ. Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst. 2011 May 4;103(9):763-773.

Rini BI, Angelov L. Nonsystematic approaches to the management of metastatic renal cell carcinoma. Emerging Cancer Therapeutics. 2011;2(1):89-99.

Rini BI, Campbell SC, Zhou M. Malignant angiomyolipoma: a rare entity with unusual biology. Oncology (Williston Park). 2011 Aug;25(9):840-841.

Rini BI, Escudier B, Tomczak P, Kaprin A, Szczylik C, Hutson TE, Michaelson MD, Gorbunova VA, Gore ME, Rusakov IG, Negrier S, Ou YC, Castellano D, Lim HY, Uemura H, Tarazi J, Cella D, Chen C, Rosbrook B, Kim S, Motzer RJ. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial. Lancet. 2011 Dec 3;378(9807):1931-1939.

Rizzi MD, Weil RJ, Lorenz RR. Authors' reply to commentary entitled "Response to research letter titled 'Severe transient hypertension after greater palatine foramen block in a patient taking midodrine'". Am J Otolaryngol. 2011 Nov-Dec;32(6):635-636.

Robinson C, Suh J. In Reply to Dr. Azoury et al [Postoperative radiation for prevention of heterotopic ossification of the elbow]. Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):636.

Rosen LS, Senzer N, Mekhail T, Ganapathi R, Chai F, Savage RE, Waghorne C, Abbadessa G, Schwartz B, Dreicer R. A phase I dose-escalation study of tivantinib (ARQ 197) in adult patients with metastatic solid tumors. Clin Cancer Res. 2011 Dec 15;17(24):7754-7764.

Rosen MP, Ding A, Blake MA, Baker ME, Cash BD, Fidler JL, Grant TH, Greene FL, Jones B, Katz DS, Lalani T, Miller FH, Small WC, Spottswood S, Sudakoff GS, Tulchinsky M, Warshauer DM, Yee J, Coley BD. ACR Appropriateness Criteria® right lower quadrant painsuspected appendicitis. J Am Coll Radiol. 2011 Nov;8(11):749-755.

Rossi CJ, Jr., Hsu ICJ, Abdel-Wahab M, Arterbery VE, Ciezki JP, Frank SJ, Hahn NM, Moran BJ, Rosenthal SA, Merrick G. ACR appropriateness criteria postradical prostatectomy irradiation in prostate cancer. Am J Clin Oncol. 2011 Feb;34(1):92-98.

Rubin BP, Nishijo K, Chen HIH, Yi X, Schuetze DP, Pal R, Prajapati SI, Abraham J, Arenkiel BR, Chen QR, Davis S, McCleish AT, Capecchi MR, Michalek JE, Zarzabal LA, Khan J, Yu Z, Parham DM, Barr FG, Meltzer PS, Chen Y, Keller C. Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma. Cancer Cell. 2011 Feb 15;19(2):177-191.

Rusmevichientong A, Das Gupta J, Elias PS, Silverman RH, Chow SA. Analysis of single-nucleotide polymorphisms in patient-derived retrovirus integration sites reveals contamination from cell lines acutely infected by xenotropic murine leukemia virus-related virus. J Virol. 2011 Dec;85(23):12830-12834.

Russell JO, Hoschar AP, Scharpf J. Papillary squamous cell carcinoma of the head and neck: a clinicopathologic series. Am J Otolaryngol. 2011 Nov-Dec;32(6):557-563.

Sachdeva R, Schoenfield L, Marcotty A, Singh AD. Retinoblastoma with autoinfarction presenting as orbital cellulitis. J AAPOS. 2011 Jun;15(3):302-304.

Sachdeva R, Turell ME, Meadows SR, Emch TM, Singh AD. Congenital intradiploic arachnoid cyst presenting as painless proptosis. J AAPOS. 2011 Dec;15(6):601-603.

Sade B, Oya S, Lee JH. Non-watertight dural reconstruction in meningioma surgery: results in 439 consecutive patients and a review of the literature. J Neurosurg. 2011 Mar;114(3):714-718.

Sadeghi S, Barzi A, Kattan MW, Meropol NJ. Screening for Lynch syndrome in the general population-letter. Cancer Prev Res (Phila ). 2011 Mar;4(3):471.

Sahiner UM, Birben E, Erzurum S, Sackesen C, Kalayci O. Oxidative stress in asthma. World Allergy Organiz J. 2011 Oct;4(10):151-158.

Sakamoto FA, Winalski CS, Fritchie K, Lietman SA, Sundaram M. Radiologic case study [Dedifferentiated liposarcoma]. Orthopedics. 2011 Aug 1;34(8):561, 627-631.

Salem M, Garcia JA. Abiraterone acetate, a novel adrenal inhibitor in metastatic castration-resistant prostate cancer. Curr Oncol Rep. 2011 Apr;13(2):92-96.

Salem M, Gilligan T. Serum tumor markers and their utilization in the management of germ-cell tumors in adult males. Expert Rev Anticancer Ther. 2011 Jan;11(1):1-4.

Samala RV, Navas V, Saluke E, Ciocon JO. Heart failure in frail, older patients: We can do 'MORE'. Cleve Clin J Med. 2011 Dec;78(12):837-845.

Samplaski MK, Zhou M, Lane BR, Herts B, Campbell SC. Renal mass sampling: An enlightened perspective. Int J Urol. 2011 Jan;18(1):5-19.

Samplaski MK, Heston W, Elson P, Magi-Galluzzi C, Hansel DE. Folate hydrolase (prostate-specific membrane [corrected] antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature [Erratum in: Mod Pathol. 2011 Nov;24(11):1531]. Mod Pathol. 2011 Nov;24(11):1521-1529.

Sanchez JA, Dejulius KL, Bronner M, Church JM, Kalady MF. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer. Inflamm Bowel Dis. 2011 Sep;17(9):1966-1970.

Saraf S, Farooqui M, Infusino G, Oza B, Sidhwani S, Gowhari M, Vara S, Gao W, Krauz L, Lavelle D, Desimone J, Molokie R, Saunthararajah Y. Standard clinical practice underestimates the role and significance of erythropoietin deficiency in sickle cell disease. Br J Haematol. 2011 May;153(3):386-392.

Sayanagi K, Pelayes DE, Kaiser PK, Singh AD. 3D Spectral domain optical coherence tomography findings in choroidal tumors. Eur J Ophthalmol. 2011 May-Jun;21(3):271-275.

Schelman WR, Liu G, Wilding G, Morris T, Phung D, Dreicer R. A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancer. Invest New Drugs. 2011 Feb;29(1):118-125.

Schoffski P, Garcia JA, Stadler WM, Gil T, Jonasch E, Tagawa ST, Smitt M, Yang X, Oliner KS, Anderson A, Zhu M, Kabbinavar F. A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma. BJU Int. 2011 Sep;108(5):679-686.

Schwandt A, Garcia JA, Elson P, Wyckhouse J, Finke JH, Ireland J, Triozzi P, Zhou M, Dreicer R, Rini BI. Clinical and immunomodulatory effects of celecoxib plus interferon-

alpha in metastatic renal cell carcinoma patients with COX-2 tumor immunostaining. J Clin Immunol. 2011 Aug;31(4):690-698.

Scott JG, Suh JH, Elson P, Barnett GH, Vogelbaum MA, Peereboom DM, Stevens GH, Elinzano H, Chao ST. Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases. Neuro Oncol. 2011 Apr;13(4):428-436.

Sears J, Bena J, Singh AD. CATT: Into the eye of a tiger. Br J Ophthalmol. 2011 Jun;95(6):761.

Sekeres M. On (cology) language. Oncology Times. 2011 Feb 25;33(4):16.

Sekeres MA. The Avastin story. N Engl J Med. 2011 Oct 13;365(15):1454-1455.

Sekeres MA. If Nostradamus were treated for MDS. Blood. 2011 Jan 13;117(2):374-375.

Sekeres MA. The baby whisperer. J Clin Oncol. 2011 Dec 1;29(34):4584-4585.

Sekeres MA. Lenalidomide in MDS: 4th time's a charm. Blood. 2011 Oct 6;118(14):3757-3758.

Sekeres MA, Gundacker H, Lancet J, Advani A, Petersdorf S, Liesveld J, Mulford D, Norwood T, Willman CL, Appelbaum FR, List AF. A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605. Blood. 2011 Jul 21;118(3):523-528.

Sekeres MA, Steensma DP. A piece of my mind. The road warriors. JAMA. 2011 Aug 24;306(8):805-806.

Sekeres MA, Maciejewski JP, Erba HP, Afable M, Englehaupt R, Sobecks R, Advani A, Seel S, Chan J, Kalaycio ME. A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia. Cancer. 2011 Mar 15;117(6):1253-1261.

Sekeres MA, Kantarjian H, Fenaux P, Becker P, Boruchov A, Guerci-Bresler A, Hu K, Franklin J, Wang YM, Berger D. Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes. Cancer. 2011 Mar 1;117(5):992-1000.

Sekeres MA, O'Keefe C, List AF, Paulic K, Afable M, Englehaupt R, Maciejewski JP. Demonstration of additional benefit in adding lenalidomide to azacitidine in patients with higher-risk myelodysplastic syndromes. Am J Hematol. 2011 Jan;86(1):102-103.

Sekeres MA. Epidemiology, natural history, and practice patterns of patients with myelodysplastic syndromes in 2010. J Natl Compr Canc Netw. 2011 Jan;9(1):57-63.

Sekeres MA, Maciejewski JP, List AF, Steensma DP, Artz A, Swern AS, Scribner P, Huber J, Stone R. Perceptions of disease state, treatment outcomes, and prognosis

among patients with myelodysplastic syndromes: results from an internet-based survey. Oncologist. 2011;16(6):904-911.

Sekeres MA. Tricking or treating myelodysplastic syndromes. Oncology (Williston Park). 2011 May;25(6):488, 490, 492.

Serio B, Selleri C, Maciejewski JP. Impact of immunogenetic polymorphisms in bone marrow failure syndromes. Mini Rev Med Chem. 2011 Jun 1;11(6):544-552.

Seth R, Revenaugh PC, Vidimos AT, Scharpf J, Somani AK, Fritz MA. Simultaneous intraoperative Mohs clearance and reconstruction for advanced cutaneous malignancies. Arch Facial Plast Surg. 2011 Nov-Dec;13(6):404-410.

Seth R, Manz RM, Dahan IJ, Nuara MJ, Meltzer NE, McLennan G, Alam DS. Comprehensive analysis of the anterolateral thigh flap vascular anatomy. Arch Facial Plast Surg. 2011 Sep-Oct;13(5):347-354.

Seth R, Scharpf J. Medication ineffectiveness due to Zenker diverticulum in a compliant patient. Otolaryngol Head Neck Surg. 2011 Nov;145(5):872-873.

Seyidova-Khoshknabi D, Davis MP, Walsh D. Review article: a systematic review of cancer-related fatigue measurement questionnaires. Am J Hosp Palliat Care. 2011 Mar;28(2):119-129.

Shanbhogue A, Shah SN, Zaheer A, Prasad SR, Takahashi N, Vikram R. Hepatocellular adenomas: current update on genetics, taxonomy, and management. J Comput Assist Tomogr. 2011 Mar-Apr;35(2):159-166.

Shantha Kumara HMC, Tohme ST, Yan X, Nasar A, Senagore AJ, Kalady MF, Hyman N, Kim IY, Whelan RL. Plasma levels of angiostatin and endostatin remain unchanged for the first 3 weeks after colorectal cancer surgery. Surg Endosc. 2011 Jun;25(6):1939-1944.

Shantha Kumara HMC, Cabot JC, Yan X, Herath SAC, Luchtefeld M, Kalady MF, Feingold DL, Baxter R, Whelan RL. Minimally invasive colon resection is associated with a persistent increase in plasma PlGF levels following cancer resection. Surg Endosc. 2011 Jul;25(7):2153-2158.

Shantha Kumara HMC, Tohme ST, Kim IY, Kim DG, Kalady MF, Luchtefeld M, Hoffman K, Dimaggio V, Whelan RL. Minimally invasive colorectal resection is associated with a transient increase in plasma hepatocyte growth factor levels early after surgery for colon cancer. Surg Innov. 2011 Sep;18(3):254-258.

Sharma P, Rogers KA, Suppiah S, Molinaro RJ, Onlamoon N, Hackett J, Jr., Schochetman G, Klein EA, Silverman RH, Villinger F. Sexual transmission of XMRV: A potential infection route. Adv Virol. 2011;2011:965689.

Sharp RR, Goldlust ME, Eng C. Addressing gaps in physician education using personal genomic testing. Genet Med. 2011 Aug;13(8):750-751.

Shats I, Gatza ML, Chang JT, Mori S, Wang J, Rich J, Nevins JR. Using a stem cell-based signature to guide therapeutic selection in cancer. Cancer Res. 2011 Mar 1;71(5):1772-1780.

Shi I, Sadraei NH, Duan ZH, Shi T. Aberrant signaling pathways in squamous cell lung carcinoma. Cancer Inform. 2011;10:273-285.

Shin JH, Chao ST, Angelov L. Stereotactic radiosurgery for spinal metastases: update on treatment strategies. J Neurosurg Sci. 2011 Sep;55(3):197-209.

Shinohara K, Greenfield S, Pan H, Vasanji A, Kumagai K, Midura RJ, Kiedrowski M, Penn MS, Muschler GF. Stromal cell-derived factor-1 and monocyte chemotactic protein-3 improve recruitment of osteogenic cells into sites of musculoskeletal repair. J Orthop Res. 2011 Jul;29(7):1064-1069.

Shoemaker LK, Estfan B, Induru R, Walsh TD. Symptom management: An important part of cancer care. Cleve Clin J Med. 2011 Jan;78(1):25-34.

Sicheri F, Silverman RH. Putting the brakes on the unfolded protein response. J Cell Biol. 2011 Apr 4;193(1):17-19.

Simmons MN, Fergany AF, Campbell SC. Effect of parenchymal volume preservation on kidney function after partial nephrectomy. J Urol. 2011 Aug;186(2):405-410.

Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011 Sep;118(9):1881-1885.

Siomin V, Lin JL, Marko NF, Barnett GH, Toms SA, Chao ST, Angelov L, Vogelbaum MA, Navaratne K, Suh JH, Weil RJ. Stereotactic radiosurgical treatment of brain metastases to the choroid plexus. Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1134-1142.

Siskin GP, Haskal ZJ, McLennan G, Dake MD, Haacke EM, McDonald S, Royal W, III, Vedantham S, Hubbard D, Sclafani SJ, Andrews RT, Sauder H. Development of a research agenda for evaluation of interventional therapies for chronic cerebrospinal venous insufficiency: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol. 2011 May;22(5):587-593.

Smith AK, Stephenson AJ, Lane BR, Larson BT, Thomas AA, Gong MC, Jones JS, Campbell SC, Hansel DE. Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology. 2011 Jul;78(1):82-86.

Smith SD, Moskowitz CH, Dean R, Pohlman B, Sobecks R, Copelan E, Andresen S, Bolwell B, Maragulia JC, Vanak JM, Sweetenham J, Moskowitz AJ. Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres. Br J Haematol. 2011 May;153(3):358-363.

Smith SD, Bolwell BJ, Rybicki LA, Kang T, Dean R, Advani A, Thakkar S, Sobecks R, Kalaycio M, Pohlman B, Sweetenham JW. Comparison of outcomes after auto-SCT for patients with relapsed diffuse large B-cell lymphoma according to previous therapy with rituximab. Bone Marrow Transplant. 2011 Feb;46(2):262-266.

Sobecks RM, Copelan E, Kalaycio M, Askar M, Rybicki L, Serafino S, Serafin M, Macklis R, Dean R, Pohlman B, Andresen S, Bolwell BJ. Multiple unit umbilical cord blood transplantation with total body irradiation, etoposide and antithymocyte globulin for adult haematological malignancy patients. Br J Haematol. 2011 Jan;152(1):116-119.

Sobecks RM, Askar M, Thomas D, Rybicki L, Kalaycio M, Dean R, Avery R, Mossad S, Copelan E, Bolwell BJ. Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotype. Exp Clin Transplant. 2011 Feb;9(1):7-13.

Somanath PR, Podrez EA, Chen J, Ma Y, Marchant K, Antoch M, Byzova TV. Deficiency in core circadian protein Bmal1 is associated with a prothrombotic and vascular phenotype. J Cell Physiol. 2011 Jan;226(1):132-140.

Soriano A, Davis MP. Malignant bowel obstruction: Individualized treatment near the end of life. Cleve Clin J Med. 2011 Mar;78(3):197-206.

Sperduto PW, Chao ST, Suh J, Sneed PK, Luo X, Roberge D, Bhatt A, Mehta MP, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM. Reply to Drs. Mulvenna and Holt. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1194-1195.

Sproat L, Bolwell B, Rybicki L, Dean R, Sobecks R, Pohlman B, Andresen S, Sweetenham J, Copelan E, Kalaycio M. Vitamin D level after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant. 2011 Jul;17(7):1079-1083.

Stein BL, Williams DM, O'Keefe C, Rogers O, Ingersoll RG, Spivak JL, Verma A, Maciejewski JP, McDevitt MA, Moliterno AR. Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes. Haematologica. 2011 Oct;96(10):1462-1469.

Stephans K, Khouri A, Machtay M. The role of PET in the evaluation, treatment, and ongoing management of lung cancer. PET Clin. 2011 Jul;6(3):265-274.

Stephans K, Khouri A, Machtay M. The role of PET in the evaluation, treatment, and ongoing management of lung cancer. PET Clin. 2011 Apr;6(2):177-184.

Stephenson AJ, Aprikian AG, Gilligan TD, Oldenburg J, Powles T, Toner GC, Waters WB. Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009. Urology. 2011 Oct;78(4 Suppl):S444-S455.

Stiff PJ, Micallef I, Nademanee AP, Stadtmauer EA, Maziarz RT, Bolwell BJ, Bridger G, Marulkar S, Hsu FJ, DiPersio JF. Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma. Biol Blood Marrow Transplant. 2011 Aug;17(8):1146-1153.

Stock W, Douer D, DeAngelo DJ, Arellano M, Advani A, Damon L, Kovacsovics T, Litzow M, Rytting M, Borthakur G, Bleyer A. Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel. Leuk Lymphoma. 2011 Dec;52(12):2237-2253.

Straus DJ, Johnson JL, Lacasce AS, Bartlett NL, Kostakoglu L, Hsi ED, Schoder H, Hall NC, Jung SH, Canellos GP, Schwartz LH, Takvorian RW, Juweid ME, Cheson BD. Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET. Blood. 2011 May 19;117(20):5314-5320.

Sucheston LE, Zhao H, Yao S, Zirpoli G, Liu S, Barlow WE, Moore HCF, Budd GT, Hershman DL, Davis W, Ciupak GL, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Livingston RB, Albain KS, Hayes DF, Ambrosone CB. Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221). Breast Cancer Res Treat. 2011 Dec;130(3):993-1002.

Sukhdeo K, Hambardzumyan D, Rich JN. Glioma development: where did it all go wrong? Cell. 2011 Jul 22;146(2):187-188.

Sullivan M, Rybicki LA, Winter A, Hoffmann MM, Reiermann S, Linke H, Arbeiter K, Patzer L, Budde K, Hoppe B, Zeier M, Lhotta K, Bock A, Wiech T, Gaspert A, Fehr T, Woznowski M, Berisha G, Malinoc A, Goek ON, Eng C, Neumann HPH. Age-related penetrance of hereditary atypical hemolytic uremic syndrome. Ann Hum Genet. 2011 Nov;75(6):639-647.

Sun J, Zborowski M, Chalmers JJ. Quantification of both the presence, and oxidation state, of Mn in Bacillus atrophaeus spores and its imparting of magnetic susceptibility to the spores. Biotechnol Bioeng. 2011 May;108(5):1119-1129.

Sun Y, Perera J, Rubin BP, Huang J. SYT-SSX1 (synovial sarcoma translocated) regulates PIASy ligase activity to cause overexpression of NCOA3 protein. J Biol Chem. 2011 May 27;286(21):18623-18632.

Sweetenham JW, Polliack A. Progressive transformation of germinal centers and Hodgkin lymphoma: more insights but maybe more confusion? Leuk Lymphoma. 2011 Nov;52(11):2041-2042.

Sweetenham JW. "Pet Negativity" -The new goal of cytoreductive therapy in Hodgkin's lymphoma? Biol Blood Marrow Transplant. 2011 Nov;17(11):1569-1570.

Sweetenham JW. Molecular signatures in the diagnosis and management of diffuse large B-cell lymphoma. Curr Opin Hematol. 2011 Jul;18(4):288-292.

Sweetenham JW, Freedman AS. Early initial therapy of advanced follicular lymphoma: the need for vigilance. Leuk Lymphoma. 2011 Mar;52(3):355-357.

Tamaskar I, Dhillon J, Pili R. Resistance to angiogenesis inhibitors in renal cell carcinoma. Clin Adv Hematol Oncol. 2011 Feb;9(2):101-110.

Tan MH, Mester J, Peterson C, Yang Y, Chen JL, Rybicki LA, Milas K, Pederson H, Remzi B, Orloff MS, Eng C. A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet. 2011 Jan 7;88(1):42-56.

Tan MH, Eng C. Testicular microlithiasis: recent advances in understanding and management. Nat Rev Urol. 2011 Mar;8(3):153-163.

Tan N, Klein EA, Li J, Moussa AS, Jones JS. Statin use and risk of prostate cancer in a population of men who underwent biopsy. J Urol. 2011 Jul;186(1):86-90.

Tanas MR, Sboner A, Oliveira AM, Erickson-Johnson MR, Hespelt J, Hanwright PJ, Flanagan J, Luo Y, Fenwick K, Natrajan R, Mitsopoulos C, Zvelebil M, Hoch BL, Weiss SW, Debiec-Rychter M, Sciot R, West RB, Lazar AJ, Ashworth A, Reis-Filho JS, Lord CJ, Gerstein MB, Rubin MA, Rubin BP. Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Sci Transl Med. 2011 Aug 31;3(98):98ra82.

Thomas AA, Campbell SC. Small renal masses: Toward more rational treatment. Cleve Clin J Med. 2011 Aug;78(8):539-547.

Thomas AA, Demirjian S, Lane BR, Simmons MN, Goldfarb DA, Subramanian VS, Campbell SC. Acute kidney injury: novel biomarkers and potential utility for patient care in urology. Urology. 2011 Jan;77(1):5-11.

Timothy AD, Jegalian A, Lichtin AE. A 54-year-old woman with pancytopenia. Cleve Clin J Med. 2011 Dec;78(12):815-820.

Tiu RV, Traina F, Sekeres MA. Clofarabine for myelodysplastic syndromes. Expert Opin Investig Drugs. 2011 Jul;20(7):1005-1014.

Tiu RV, Gondek LP, O'Keefe CL, Elson P, Huh J, Mohamedali A, Kulasekararaj A, Advani AS, Paquette R, List AF, Sekeres MA, McDevitt MA, Mufti GJ, Maciejewski JP. Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies. Blood. 2011 Apr 28;117(17):4552-4560.

Tiu RV, Sekeres MA. Lenalidomide in del 5q MDS: Responses and side effects revisited. Leuk Res. 2011 Nov;35(11):1440-1441.

Tiu RV, Visconte V, Traina F, Schwandt A, Maciejewski JP. Updates in cytogenetics and molecular markers in MDS. Curr Hematol Malig Rep. 2011 Jun;6(2):126-135.

Tong GX, Memeo L, Colarossi C, Hamele-Bena D, Magi-Galluzzi C, Zhou M, Lagana SM, Harik L, Oliver-Krasinski JM, Mansukhani M, Falcone L, Hibshoosh H, O'Toole K. PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract. Am J Surg Pathol. 2011 Oct;35(10):1473-1483.

Torgerson DG, Ampleford EJ, Chiu GY, Gauderman WJ, Gignoux CR, Graves PE, Himes BE, Levin AM, Mathias RA, Hancock DB, Baurley JW, Eng C, Stern DA, Celedon JC, Rafaels N, Capurso D, Conti DV, Roth LA, Soto-Quiros M, Togias A, Li X, Myers RA, Romieu I, Berg DJVD, Hu D, Hansel NN, Hernandez RD, Israel E, Salam MT, Galanter J, Avila PC, Avila L, Rodriquez-Santana JR, Chapela R, Rodriguez-Cintron W, Diette

GB, Adkinson NF, Abel RA, Ross KD, Shi M, Faruque MU, Dunston GM, Watson HR, Mantese VJ, Ezurum SC, Liang L, Ruczinski I, Ford JG, Huntsman S, Chung KF, Vora H, Li X, Calhoun WJ, Castro M, Sienra-Monge JJ, del Rio-Navarro B, Deichmann KA, Heinzmann A, Wenzel SE, Busse WW, Gern JE, Lemanske RF, Jr., Beaty TH, Bleecker ER, Raby BA, Meyers DA, London SJ, Gilliland FD, Burchard EG, Martinez FD, Weiss ST, Williams LK, Barnes KC, Ober C, Nicolae DL. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet. 2011;43(9):887-892.

Torres V, Triozzi P, Eng C, Tubbs R, Schoenfiled L, Crabb JW, Saunthararajah Y, Singh AD. Circulating tumor cells in uveal melanoma. Future Oncol. 2011 Jan;7(1):101-109.

Torres VLL, Brugnoni N, Kaiser PK, Singh AD. Optical coherence tomography enhanced depth imaging of choroidal tumors. Am J Ophthalmol. 2011 Apr;151(4):586-593.

Trask PC, Bushmakin AG, Cappelleri JC, Tarazi J, Rosbrook B, Bycott P, Kim S, Stadler WM, Rini B. Baseline patient-reported kidney cancer-specific symptoms as an indicator for median survival in sorafenib-refractory metastatic renal cell carcinoma. J Cancer Surviv. 2011 Sep;5(3):255-262.

Traudt K, Ciezki J, Klein EA. Low-dose-rate brachytherapy as salvage treatment of local prostate cancer recurrence after radical prostatectomy. Urology. 2011 Jun;77(6):1416-1419.

Triozzi PL, Aldrich W, Singh A. Effects of interleukin-1 receptor antagonist on tumor stroma in experimental uveal melanoma. Invest Ophthalmol Vis Sci. 2011;52(8):5529-5535.

Triozzi PL, Borden EC. VB-111 for cancer. Expert Opin Biol Ther. 2011 Dec;11(12):1669-1676.

Triozzi PL, Singh AD. Blood biomarkers of uveal melanoma metastasis. Br J Ophthalmol. 2011 Jan;95(1):3-4.

Triozzi PL, Aldrich W, Ponnazhagan S. Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll-like receptor agonists. Cancer Gene Ther. 2011 Dec;18(12):850-858.

Triozzi PL, Tuthill RJ, Borden E. Re-inventing intratumoral immunotherapy for melanoma. Immunotherapy. 2011 May;3(5):653-671.

Tripp B. Managing asparaginase-related toxicity in adult patients. Oncology Nurse Advisor. 2011 Jan-Feb;23-25, 32.

Turell ME, Leonardy NJ, Singh AD. A unique presentation of grouped congenital hypertrophy of the retinal pigment epithelium. Ophthalmic Genet. 2011 Sep;32(3):162-164.

Uberti JP, Agovi MA, Tarima S, Haagenson M, Gandham S, Anasetti C, Baker KS, Bolwell BJ, Bornhauser M, Chan KW, Copelan E, Davies SM, Finke J, Hale GA, Kollman

C, McCarthy PL, Ratanatharathorn V, Ringden O, Weisdorf DJ, Rizzo JD. Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia. Bone Marrow Transplant. 2011 Jan;46(1):34-43.

Valent J, Schiffer CA. Thrombocytopenia and platelet transfusions in patients with cancer. Cancer Treat Res. 2011;157:251-265.

Valent JN, Schiffer CA. Prevalence of large granular lymphocytosis in patients with chronic myelogenous leukemia (CML) treated with dasatinib. Leuk Res. 2011 Jan;35(1):e1-e3.

Van den Bent MJ, Wefel JS, Schiff D, Taphoorn MJB, Jaeckle K, Junck L, Armstrong T, Choucair A, Waldman AD, Gorlia T, Chamberlain M, Baumert BG, Vogelbaum MA, Macdonald DR, Reardon DA, Wen PY, Chang SM, Jacobs AH. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol. 2011 Jun;12(6):583-593.

van Dongen R, Cohen SP, Van Kleef M, Mekhail N, Huygen F. 22. Traumatic plexus lesion. Pain Pract. 2011 Jul-Aug;11(4):414-420.

van Eijs F, Stanton-Hicks M, Van Zundert J, Faber CG, Lubenow TR, Mekhail N, Van Kleef M, Huygen F. Evidence-based interventional pain medicine according to clinical diagnoses. 16. Complex regional pain syndrome. Pain Pract. 2011 Jan-Feb;11(1):70-87.

Van Kleef M, Staats P, Mekhail N, Huygen F. 24. Chronic refractory angina pectoris. Pain Pract. 2011 Sep-Oct;11(5):476-482.

Van Wijck AJM, Wallace M, Mekhail N, Van Kleef M. Evidence-based interventional pain medicine according to clinical diagnoses. 17. Herpes zoster and post-herpetic neuralgia. Pain Pract. 2011 Jan-Feb;11(1):88-97.

Van Zundert J, Hartrick C, Patijn J, Huygen F, Mekhail N, Van Kleef M. Evidence-based interventional pain medicine according to clinical diagnoses. Pain Pract. 2011 Sep-Oct;11(5):423-429.

VanAntwerp AE, Raymond SM, Addington MC, Gajdos S, Vassil A, Xia P. Dosimetric evaluation between megavoltage cone-beam computed tomography and body mass index for intracranial, thoracic, and pelvic localization. Med Dosim. 2011 Autumn;36(3):284-291.

Veizi IE, Hayek SM, Narouze S, Pope JE, Mekhail N. Combination of intrathecal opioids with bupivacaine attenuates opioid dose escalation in chronic noncancer pain patients. Pain Med. 2011 Oct;12(10):1481-1489.

Venere M, Fine HA, Dirks PB, Rich JN. Cancer stem cells in gliomas: Identifying and understanding the apex cell in cancer's hierarchy. Glia. 2011 Aug;59(8):1148-1154.

Vickers AJ, Savage CJ, Bianco FJ, Klein EA, Kattan MW, Secin FP, Guilloneau BD, Scardino PT. Surgery confounds biology: The predictive value of stage-, grade- and

prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experience. Int J Cancer. 2011 Apr 1;128(7):1697-1702.

Vissers KCP, Besse K, Wagemans M, Zuurmond W, Giezeman MJMM, Lataster A, Mekhail N, Burton AW, Van Kleef M, Huygen F. 23. Pain in patients with cancer. Pain Pract. 2011 Sep-Oct;11(5):453-475.

Vogel JD, Lian L, Kalady MF, de Campos-Lobato LF, Alves-Ferreira PC, Remzi FH. Hand-assisted laparoscopic right colectomy: how does it compare to conventional laparoscopy? J Am Coll Surg. 2011 Mar;212(3):367-372.

von Ducker L, Walz MK, Voss C, Arnold G, Eng C, Neumann HPH. Laparoscopic organ-sparing resection of von hippel-lindau disease-associated pancreatic neuroendocrine tumors. World J Surg. 2011 Mar;35(3):563-567.

Vu HT, Lopez R, Bennett A, Burke CA. Individuals with sessile serrated polyps express an aggressive colorectal phenotype. Dis Colon Rectum. 2011 Oct;54(10):1216-1223.

Wada DA, Law ME, Hsi ED, DiCaudo DJ, Ma L, Lim MS, De Souza A, Comfere NI, Weenig RH, Macon WR, Erickson LA, Ozsan N, Ansell SM, Dogan A, Feldman AL. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies. Mod Pathol. 2011 Apr;24(4):596-605.

Walsh D, Aktas A, Hullihen B, Induru RR. What is palliative medicine? Motivations and skills. Am J Hosp Palliat Care. 2011 Feb;28(1):52-58.

Walz J, Joniau S, Chun FK, Isbarn H, Jeldres C, Yossepowitch O, Chao-Yu H, Klein EA, Scardino PT, Reuther A, Van Poppel H, Graefen M, Huland H, Karakiewicz PI. Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy. BJU Int. 2011 Mar;107(5):765-770.

Wang AZ, Li L, Zhang B, Shen GQ, Wang QK. Association of SNP rs17465637 on chromosome 1q41 and rs599839 on 1p13.3 with myocardial infarction in an American caucasian population. Ann Hum Genet. 2011 Jul;75(4):475-482.

Wang C, Cao D, Wang Q, Wang DZ. Synergistic activation of cardiac genes by myocardin and tbx5. PLoS ONE. 2011;6(8):e24242.

Wang D, Olman MA, Stewart J, Jr., Tipps R, Huang P, Sanders PW, Toline E, Prayson RA, Lee J, Weil RJ, Palmer CA, Gillespie GY, Liu WM, Pieper RO, Guan JL, Gladson CL. Downregulation of FIP200 induces apoptosis of glioblastoma cells and microvascular endothelial cells by enhancing Pyk2 activity. PLoS ONE. 2011;6(5):e19629.

Wang X, Ma D, Olson WC, Heston WDW. In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen. Mol Cancer Ther. 2011 Sep;10(9):1728-1739.

Wang Y, Romigh T, He X, Tan MH, Orloff MS, Silverman RH, Heston WD, Eng C. Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers. Oncogene. 2011 Oct 20;30(42):4327-4338.

Warde P, Huddart R, Bolton D, Heidenreich A, Gilligan T, Fossa S. Management of localized seminoma, stage I-II: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009. Urology. 2011 Oct;78(4 Suppl):S435-S443.

Wartak SA, Bartholomew JR. In reply [Dabigatran]. Cleve Clin J Med. 2011 Dec;78(12):787.

Wartak SA, Bartholomew JR. Dabigatran: Will it change clinical practice? Cleve Clin J Med. 2011 Oct;78(10):657-664.

Watts KE, Hansel DE, MacLennan GT. Clear cell sarcoma of the kidney. J Urol. 2011 Jan;185(1):279-280.

Wedes SH, Wu W, Comhair SAA, McDowell KM, DiDonato JA, Erzurum SC, Hazen SL. Urinary bromotyrosine measures asthma control and predicts asthma exacerbations in children. J Pediatr. 2011 Aug;159(2):248-255.

Weight CJ, Lythgoe C, Unnikrishnan R, Lane BR, Campbell SC, Fergany AF. Partial nephrectomy does not compromise survival in patients with pathologic upstaging to pT2/pT3 or high-grade renal tumors compared with radical nephrectomy. Urology. 2011 May;77(5):1142-1146.

Wen PY, Van den Bent MJ, Macdonald DR, Tsien C, Vogelbaum MA, Chang SM. Reply to P. Farace et al [Baseline preadjuvant magnetic resonance imaging for response assessment and for planning radiotherapy in glioblastoma]. J Clin Oncol. 2011 Feb 20;29(6):e149.

Wen PY, Schiff D, Cloughesy TF, Reardon DA, Batchelor TT, Chabner BA, Flaherty K, de Groot JF, Gilbert MR, Galanis E, Chang SM, Schwartz GK, Peereboom D, Mehta MP, Yung WKA, Grossman SA, Prados MD, Deangelis LM. It is time to include patients with brain tumors in phase I trials in oncology. J Clin Oncol. 2011 Aug 20;29(24):3211-3213.

Wen PY, Van den Bent MJ, Macdonald DR, Vogelbaum MA, Chang SM. Reply to A.A. Brandes et al [New agents and new end points for recurrent gliomas]. J Clin Oncol. 2011 Mar 20;29(9):e247.

Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D, Sorror ML, Horowitz MM, Bolwell B, Rizzo JD, Socie G. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol. 2011 Jun 1;29(16):2230-2239.

Witzig TE, Fishkin P, Gordon LI, Gregory SA, Jacobs S, Macklis R, McLaughlin P, Press O, Zelenetz AD. Treatment recommendations for radioimmunotherapy in follicular lymphoma: a consensus conference report. Leuk Lymphoma. 2011 Jul;52(7):1188-1199.

Wolff A, Vanduynhoven E, Van Kleef M, Huygen F, Pope JE, Mekhail N. 21. Phantom pain. Pain Pract. 2011 Jul-Aug;11(4):403-413.

Wolfson AH, Bae K, Komaki R, Meyers C, Movsas B, Le Pechoux C, Werner-Wasik M, Videtic GMM, Garces YI, Choy H. Primary analysis of a phase II randomized trial

radiation therapy Oncology Group (RTOG) 0212: Impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):77-84.

Xu W, Erzurum SC. Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension. Comprehensive Physiology. 2011 Jan;1(1):357-372.

Xu Z, Li Y, Zhang X, Zeng F, Yuan M, Liu M, Wang QK, Liu JY. Identification and molecular characterization of two novel mutations in COL1A2 in two Chinese families with osteogenesis imperfecta. J Genet Genomics. 2011 Apr 20;38(4):149-156.

Yamaguchi Y, Simmons MN, Campbell SC. Small renal masses: risk prediction and contemporary management. Hematol Oncol Clin North Am. 2011 Aug;25(4):717-736.

Yan H, Choi AJ, Lee BH, Ting AH. Identification and functional analysis of epigenetically silenced micrornas in colorectal cancer cells. PLoS ONE. 2011;6(6):e20628.

Yang H, Kim C, Kim MJ, Schwendener RA, Alitalo K, Heston W, Kim I, Kim WJ, Koh GY. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer. Mol Cancer. 2011;10:36.

Yang J, Abdel-Wahab M, Ribeiro A. EUS-guided fiducial placement after radical prostatectomy before targeted radiation therapy for prostate cancer recurrence. Gastrointest Endosc. 2011 Jun;73(6):1302-1305.

Yang Q, Li L, Yang R, Shen GQ, Chen Q, Foldvary-Schaefer N, Ondo WG, Wang QK. Family-based and population-based association studies validate PTPRD as a risk factor for restless legs syndrome. Mov Disord. 2011 Feb 15;26(3):516-519.

Yang Q, Li L, Chen Q, Foldvary-Schaefer N, Ondo WG, Wang QK. Association studies of variants in MEIS1, BTBD9, and MAP2K5/SKOR1 with restless legs syndrome in a US population. Sleep Med. 2011 Sep;12(8):800-804.

Yaskiv O, Zhang X, Simmerman K, Daly T, He H, Falzarano S, Chen L, Magi-Galluzzi C, Zhou M. The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies. Am J Surg Pathol. 2011 Jul;35(7):1062-1068.

Yi T, Elson P, Mitsuhashi M, Jacobs B, Hollovary E, Budd TG, Spiro T, Triozzi P, Borden EC. Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects. Oncotarget. 2011 Dec;2(12):1155-1164.

Yie SM, Hu Z. Human leukocyte antigen-G (HLA-G) as a marker for diagnosis, prognosis and tumor immune escape in human malignancies. Histol Histopathol. 2011 Mar;26(3):409-420.

Yin L, Rao P, Elson P, Wang J, Ittmann M, Heston WD. Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expression. PLoS ONE. 2011;6(6):e21319.

Zborowski M, Chalmers JJ. Rare cell separation and analysis by magnetic sorting. Anal Chem. 2011 Nov 1;83(21):8050-8056.

Zhang A, Bogerd H, Villinger F, Gupta JD, Dong B, Klein EA, Hackett J, Jr., Schochetman G, Cullen BR, Silverman RH. In vivo hypermutation of xenotropic murine leukemia virus-related virus DNA in peripheral blood mononuclear cells of rhesus macaque by APOBEC3 proteins. Virology. 2011 Dec 5;421(1):28-33.

Zhang T, Yong SL, Drinko JK, Popovic ZB, Shryock JC, Belardinelli L, Wang QK. LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice. Int J Cardiol. 2011 Mar 3;147(2):239-245.

Zhang W, McElhinny A, Nielsen A, Wang M, Miller M, Singh S, Rueger R, Rubin BP, Wang Z, Tubbs RR, Nagle RB, Roche P, Wu P, Pestic-Dragovich L. Automated brightfield dual-color in situ hybridization for detection of mouse double minute 2 gene amplification in sarcomas. Appl Immunohistochem Mol Morphol. 2011 Jan;19(1):54-61.

Zheng Q, Dunlap SM, Zhu J, Downs-Kelly E, Rich J, Hursting SD, Berger NA, Reizes O. Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival. Endocr Relat Cancer. 2011;18(4):491-503.

Zhou L, Opalinska J, Sohal D, Yu Y, Mo Y, Bhagat T, Abdel-Wahab O, Fazzari M, Figueroa M, Alencar C, Zhang J, Kambhampati S, Parmar S, Nischal S, Hueck C, Suzuki M, Freidman E, Pellagatti A, Boultwood J, Steidl U, Sauthararajah Y, Yajnik V, Mcmahon C, Gore SD, Platanias LC, Levine R, Melnick A, Wickrema A, Greally JM, Verma A. Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q. J Biol Chem. 2011 Jul 15;286(28):25211-25223.

Zhou M, Srigley JR. Benign mimickers and potential precursors of prostatic adenocarcinoma. Diagn Histopathol. 2011 Oct;17(10):434-446.

Zhu X, Tam MDBS, Bartholomew J, Newman JS, Sands MJ, Wang W. Retrievability and device-related complications of the g2 filter: a retrospective study of 139 filter retrievals. J Vasc Interv Radiol. 2011 Jun;22(6):806-812.

Zhu X, Tam MDBS, Pierce G, McLennan G, Sands MJ, Lieber MS, Wang W. Utility of the amplatzer vascular plug in splenic artery embolization: a comparison study with conventional coil technique. Cardiovasc Intervent Radiol. 2011 Jun;34(3):522-531.

Zhuang Z, Qi M, Li J, Okamoto H, Xu DS, Iyer RR, Lu J, Yang C, Weil RJ, Vortmeyer A, Lonser RR. Proteomic identification of glutamine synthetase as a differential marker for oligodendrogliomas and astrocytomas. J Neurosurg. 2011 Oct;115(4):789-795.

Books, Whole Advani AS, Lazarus HM. Adult Acute Lymphocytic Leukemia : Biology and Treatment. Totowa, NJ: Humana, 2011.

Beriwal S, Macklis RM, Basu S. Radiation Therapy Planning With PET. Philadelphia, PA: Saunders, 2011. (PET Clinics v.6(2):105-229.)

Davis MP. Supportive Oncology. Philadelphia, PA: Elsevier/Saunders, 2011.

Mehta MP, Chang SM, Guha A, Newton HB, Vogelbaum MA. Principles and Practice of Neuro-Oncology : a Multidisciplinary Approach. New York, NY: Demos Medical, 2011.

Scardino PT, Linehan WM, Zelefsky MJ, Vogelzang NJ, Sheinfeld J, Rini BI, Bochner BH. Comprehensive Textbook of Genitourinary Oncology. 4th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2011.

Toms SA, Weil RJ. Nanoproteomics : Methods and Protocols. New York, NY: Humana Press, 2011.

Videtic GMM, Vassil AD. Handbook of Treatment Planning in Radiation Oncology. New York, NY: Demos Medical Pub., 2011.

Book Chapters Al-Marrawi MY, Gill IS, Bukowski RM, Rini BI. Adrenal neoplasms. In: Scardino PT, ed. Comprehensive Textbook of Genitourinary Oncology. 4th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011:835-858.

Barnett GH. Navigation for brain tumors. In: Winn HR, ed. Youmans Neurological Surgery. 6th ed. Philadelphia, PA: Elsevier/Saunders; 2011:1293-1299.

Barnett GH. Surgical navigation. In: Mehta MP, ed. Principles and Practice of Neuro-Oncology : a Multidisciplinary Approach. New York, NY: Demos Medical; 2011:392-399.

Barnett GH. Cerebellar hemorrhage. In: Mashour GA, Farag E, eds. Case Studies in Neuroanesthesia and Neurocritical Care. Cambridge, UK ; New York, NY: Cambridge University Press; 2011:38-40.

Bidros DS, Vogelbaum MA. Barriers to delivery of therapeutics to brain tumors. In: Winn HR, ed. Youmans Neurological Surgery. 6th ed. Philadelphia, PA: Elsevier/Saunders; 2011:1172-1178.

Burdick M, Macklis RM. Radioimmunotherapy for non-Hodgkin lymphoma: a clinical update. In: Speer TW, ed. Targeted Radionuclide Therapy. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011:426-440.

Burdick MJ, Stephans KL. Gastrointestinal (non-esophageal) radiotherapy. In: Videtic GMM, Vassil AD, eds. Handbook of Treatment Planning in Radiation Oncology. New York, NY: Demos Medical Pub.; 2011:101-116.

Chao ST, Suh JH. Radiation for glioblastoma. In: Mehta MP, ed. Principles and Practice of Neuro-Oncology : a Multidisciplinary Approach. New York, NY: Demos Medical; 2011:744-751.

Christodouleas JP, Lee VJ. Thyroid cancer. In: Hristov B, Lin SH, Christodouleas JP, eds. Radiation Oncology : a Question-Based Review. Philadelphia, PA: Lippincott Williams & Wilkins; 2011:183-188.

Davis MP. Cancer pain. In: Davis MP, ed. Supportive Oncology. Philadelphia, PA: Elsevier/Saunders; 2011:122-135.

Davis MP. Cancer pain. In: Olver IN, ed. The MASCC Textbook of Cancer Supportive Care and Survivorship. New York, NY: Springer; 2011:11-22.

Eng C. Cowden's syndrome. In: Wass JAH, Stewart PM, eds. Oxford Textbook of Endocrinology and Diabetes. 2nd ed. Oxford ; New York, NY: Oxford University Press; 2011:980-985.

Eyler CE, Heddleston JM, Hitomi M, Guryanova OA, Macswords JM, Flavahan WA, Hjelmeland AB, Rich JN. The cancer stem cell paradigm. In: Phinney DG, ed. Adult Stem Cells : Biology and Methods of Analysis. New York, NY: Humana Press; 2011:225-248.

Fu EX, Singh AD. Phacomatoses. In: Reynolds JD, Olitsky SE, eds. Pediatric Retina. Heidelberg ; New York, NY: Springer; 2011:159-189.

Garcia JA, Rini BI. VEGF-targeted therapy in the management of metastatic renal cell carcinoma. In: Scardino PT, ed. Comprehensive Textbook of Genitourinary Oncology. 4th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011:773-784.

Guo S, Juliano JJ. Gynecologic radiotherapy. In: Videtic GMM, Vassil AD, eds. Handbook of Treatment Planning in Radiation Oncology. New York, NY: Demos Medical Pub.; 2011:143-155.

Gutgsell TL, Kirsh KL, Meyer B, Passik SD, Pham HX, Weisenfluh S. Hospice and palliative medicine. In: South-Paul JE, Matheny SC, Lewis EL, eds. Current Diagnosis & Treatment in Family Medicine. 3rd ed. New York, NY: McGraw-Hill Medical; 2011:664-677.

Hristov B, Lee VJ. Salivary gland cancer. In: Hristov B, Lin SH, Christodouleas JP, eds. Radiation Oncology : a Question-Based Review. Philadelphia, PA: Lippincott Williams & Wilkins; 2011:165-171.

Hunter GK, Videtic GMM. Thoracic radiotherapy. In: Videtic GMM, Vassil AD, eds. Handbook of Treatment Planning in Radiation Oncology. New York, NY: Demos Medical Pub.; 2011:85-99.

Hunter GK, Vassil AD, Stockham AL, Chao ST, Videtic GMM. Soft tissue sarcoma radiotherapy. In: Videtic GMM, Vassil AD, eds. Handbook of Treatment Planning in Radiation Oncology. New York, NY: Demos Medical Pub.; 2011:181-192.

Khan M, Burke CA. Hereditary adenomatous colorectal cancer syndromes. In: Anderson JC, Kahi CJ, eds. Colorectal Cancer Screening. New York, NY: Humana Press; 2011:25-41.

Khan MK, Tendulkar RD, Stephans KL, Ciezki JP. Genitourinary radiotherapy. In: Videtic GMM, Vassil AD, eds. Handbook of Treatment Planning in Radiation Oncology. New York, NY: Demos Medical Pub.; 2011:117-141.

Kolluri R, Bartholomew JR. Vasospastic diseases. In: Jaff MR, White CJ, eds. Vascular Disease : Diagnostic and Therapeutic Approaches. Minneapolis, MN: Cardiotext; 2011:371-387.

Koyfman SA, Greskovich JF, Saxton JP. Head and neck radiotherapy. In: Videtic GMM, Vassil AD, eds. Handbook of Treatment Planning in Radiation Oncology. New York, NY: Demos Medical Pub.; 2011:41-65.

Lietman SA, Levine MA. Molecular and clinical characteristics of the McCune-Albright syndrome. In: Wass JAH, Stewart PM, eds. Oxford Textbook of Endocrinology and Diabetes. 2nd ed. Oxford ; New York, NY: Oxford University Press; 2011:970-979.

Lin SH, Lee VJ. Neck management and postoperative radiation therapy for head and neck cancers. In: Hristov B, Lin SH, Christodouleas JP, eds. Radiation Oncology : a Question-Based Review. Philadelphia, PA: Lippincott Williams & Wilkins; 2011:195-198.

Lin SH, Lee VJ. Ocular melanoma. In: Hristov B, Lin SH, Christodouleas JP, eds. Radiation Oncology : a Question-Based Review. Philadelphia, PA: Lippincott Williams & Wilkins; 2011:123-129.

Lin SH, Lee VJ. Ear cancer. In: Hristov B, Lin SH, Christodouleas JP, eds. Radiation Oncology : a Question-Based Review. Philadelphia, PA: Lippincott Williams & Wilkins; 2011:538-539.

Linehan WM, Rini BI, Yang JC. Cancer of the kidney. In: DeVita VT, Jr., Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg's Cancer : Principles & Practice of Oncology. 9th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011:1161-1182.

Lokhandwala J, Bartholomew JR. Environmental and hereditary vascular disorders. In: Jaff MR, White CJ, eds. Vascular Disease : Diagnostic and Therapeutic Approaches. Minneapolis, MN: Cardiotext; 2011:547-559.

Macklis RM. Radiation injuries in nuclear power plant operation. In: Shrieve DC, Loeffler JS, eds. Human Radiation Injury. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011:158-162.

Marko NF, Weil RJ. Preoperative evaluation. In: Mashour GA, Farag E, eds. Case Studies in Neuroanesthesia and Neurocritical Care. Cambridge, UK ; New York, NY: Cambridge University Press; 2011:177-181.

Mehta M, Vogelbaum MA, Chang S, Patel N. Neoplasms of the central nervous system. In: DeVita VT, Jr., Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg's Cancer : Principles & Practice of Oncology. 9th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011:1700-1749.

Murphy ES, Sheplan LJ, Chao ST. Pediatric radiotherapy. In: Videtic GMM, Vassil AD, eds. Handbook of Treatment Planning in Radiation Oncology. New York, NY: Demos Medical Pub.; 2011:193-212.

Ningegowda LB, Mekhail NA. Pharmacologic strategies in back pain and radiculopathy. In: Herkowitz HN, ed. Rothman-Simeone the Spine. 6th ed. Philadelphia: Saunders Elsevier; 2011:1895-1903.

Omay SB, Vogelbaum MA. Stereotactic brain biopsy. In: Mehta MP, ed. Principles and Practice of Neuro-Oncology : a Multidisciplinary Approach. New York, NY: Demos Medical; 2011:400-406.

Patel AR, Simmons MN, Campbell SC. Open radical nephrectomy for localized renal cell carcinoma. In: Scardino PT, ed. Comprehensive Textbook of Genitourinary Oncology. 4th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011:714-721.

Rice TW, Blackstone EH. Extent of lymph node dissection in esophageal cancer. In: Ferguson MK, ed. Difficult Decisions in Thoracic Surgery : an Evidence-Based Approach. 2nd ed. Dordrecht: Springer; 2011:223-231.

Rodriguez CP, Adelstein DJ. Principles of systemic chemotherapy for squamous cell head and neck cancer. In: Bernier J, ed. Head and Neck Cancer : Multimodality Management. New York, NY: Springer; 2011:281-291.

Sade B, Lee JH. Skull base anatomy, pathology, and approaches: An overview. In: Mehta MP, ed. Principles and Practice of Neuro-Oncology : a Multidisciplinary Approach. New York, NY: Demos Medical; 2011:385-391.

Shah SN, Sanyal R. CT contrast media and principles of contrast enhancement. In: Sahani DV, Samir AE, eds. Abdominal Imaging. Maryland Heights, MO: Saunders Elsevier; 2011:86-92.

Shah SN, Chowdhry AA, Sandrasegaran K. Neoplastic conditions of the mesentery and omentum. In: Sahani DV, Samir AE, eds. Abdominal Imaging. Maryland Heights, MO: Saunders Elsevier; 2011:1430-1436.

Shah SN, Nair RT. Use of positron emission tomography imaging in gynecologic cancers. In: Fielding JR, Brown DL, Thurmond AS, eds. Gynecologic Imaging. Philadelphia, PA: Elsevier/Saunders; 2011:473-483.

Shepard DR. Allergic reactions to chemotherapy. In: Davis MP, ed. Supportive Oncology. Philadelphia, PA: Elsevier/Saunders; 2011:10-15.

Sheplan LJ, Macklis RM. Lymphoma and myeloma radiotherapy. In: Videtic GMM, Vassil AD, eds. Handbook of Treatment Planning in Radiation Oncology. New York, NY: Demos Medical Pub.; 2011:157-180.

Siemionow KB, Muschler GF. Principles of bone fusion. In: Herkowitz HN, ed. Rothman-Simeone the Spine. 6th ed. Philadelphia: Saunders Elsevier; 2011:1130-1158.

Stephenson AJ, Gilligan TD. Management of low-stage nonseminomatous germ cell tumors. In: Scardino PT, ed. Comprehensive Textbook of Genitourinary Oncology. 4th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011:565-573.

Stephenson AJ, Kattan MW. Nomograms for prostate cancer decision making. In: Scardino PT, ed. Comprehensive Textbook of Genitourinary Oncology. 4th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011:92-104.

Stevens GHJ, Robles L. Neuromuscular complications. In: Davis MP, ed. Supportive Oncology. Philadelphia, PA: Elsevier/Saunders; 2011:283-291.

Stockham AL, Suh JH, Chao ST. Central nervous system radiotherapy. In: Videtic GMM, Vassil AD, eds. Handbook of Treatment Planning in Radiation Oncology. New York, NY: Demos Medical Pub.; 2011:25-39.

Stotler CJ, Copelan E. Hematopoietic stem cell transplantation in Philadelphia-positive acute lymphoblastic leukemia. In: Advani AS, Lazarus HM, eds. Adult Acute Lymphocytic Leukemia : Biology and Treatment . Totowa, NJ: Humana; 2011:305-313.

Tariman JD, Faiman B. Multiple myeloma. In: Yarbro CH, Wujcik D, Gobel BH, eds. Cancer Nursing : Principles and Practice. 7th ed. Malden, MA: Blackwell Pub.; 2011:1513-1545.

Vassil AD, Videtic GMM. Tools for simulation and treatment. In: Videtic GMM, Vassil AD, eds. Handbook of Treatment Planning in Radiation Oncology. New York, NY: Demos Medical Pub.; 2011:15-23.

Vassil AD, Pavelecky N, Magnelli AL, Videtic GMM. General physics principles. In: Videtic GMM, Vassil AD, eds. Handbook of Treatment Planning in Radiation Oncology. New York, NY: Demos Medical Pub.; 2011:1-14.

Vassil AD, Tendulkar RD. Breast radiotherapy. In: Videtic GMM, Vassil AD, eds. Handbook of Treatment Planning in Radiation Oncology. New York, NY: Demos Medical Pub.; 2011:67-84.

Vassil AD, Videtic GMM. Palliative radiotherapy. In: Videtic GMM, Vassil AD, eds. Handbook of Treatment Planning in Radiation Oncology. New York, NY: Demos Medical Pub.; 2011:213-229.

Videtic GMM. The radiation target in small-cell lung cancer. In: Jeremic B, ed. Advances in Radiation Oncology in Lung Cancer. 2nd ed. Heidelberg ; New York, NY: Springer; 2011:201-212.

Weil RJ, Oldfield EH. Cerebral edema. In: Winn HR, ed. Youmans Neurological Surgery. 6th ed. Philadelphia, PA: Elsevier/Saunders; 2011:162-168.

Wood LS. Renal cancer. In: Yarbro CH, Wujcik D, Gobel BH, eds. Cancer Nursing : Principles and Practice. 7th ed. Malden, MA: Blackwell Pub.; 2011:1634-1649.